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ABSTRACT 
 
The high long-term failure rate of synthetic vascular grafts in the replacement of small 
vessels is known to be associated with the lack of physiological signals to vascular cells causing 
adverse hemodynamic, inflammatory or coagulatory events. Current studies focus on 
developing engineered vascular devices with ability of directing cell activity in vitro and in vivo 
for tissue regeneration. It is also known that controlled molecule release from scaffolds can 
dramatically increase the scaffold ability of directing cell activities in vitro and in vivo for tissue 
regeneration. To address the mechanical and biological problems associated with graft 
materials, we demonstrated a degradable polyester-fibroin composite tubular scaffolds which 
shows well-integrated nanofibrous structure, endothelial-conducive surface and anisotropic 
mechanical property, suitable as engineered vascular constructs. 
 iv 
 
Tissue regeneration needs not only functional biomolecules providing signaling cues to 
cells and guide tissue remodeling, but also an adequate modality of molecule delivery. In fact, 
healthy tissue formation requires specific signals at well-defined place and time. To develop 
scaffolds with multi-modal presentation of biomolecules, we patterned electrospun nanofibers 
over the thickness of the 3-dimensional scaffolds by programming the deposition of 
interpenetrating networks of degradable polymers poly(ε-caprolactone) and poly(lactide-co-
glycolide) acid  in tailored proportion. Fluorescent model molecules, drug and growth factors  
were embedded in the polymeric fibers with different techniques and release profiles were 
obtained and discussed.  
Fabrication process resulted in precise gradient patterns of materials and functional 
biomolecules throughout the thickness of the scaffold. These graded materials showed 
programmable spatio-temporal control over the release. Molecule release profiles on each side 
of the scaffolds were used to determine the separation efficiency of molecule delivery, which 
achieved >90% for proteins in 200µm scaffolds. Gradient-patterned scaffolds were also used to 
program simultaneous release of two proteins to the opposite sides of the scaffold and 
sequential release of proteins to a defined space, which further demonstrate the ability of 
patterned nanofibers to spatially and temporally confine sustained release. Moreover, results 
showed that temporal release kinetics could be altered by the structural patterns. Thus, the 
hierarchically-structured scaffolds presented here may enable development of novel 
multifunctional scaffolds with defined 3D dynamic microenvironments for tissue regeneration. 
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1 INTRODUCTION 
 
1.1 Cardiovascular system and diseases 
The cardiovascular system consists of the heart and blood vessels that distribute blood 
in to the various parts of the body. The complex system of organs that contributes to the 
cardiovascular systems has a critical role in the transport of nutrients, biochemical signals and 
cellular waste product, and in the processes of oxygen/carbon dioxide exchange. Oxygenated 
blood travels from the left section of the heart to the peripheral capillaries in the peripheral 
tissues through the arteries, and from the capillaries to the heart through the venous system 
(systemic circulation). Deoxygenated blood leaves the right section of the heart through the 
pulmonary arteries and enters the lungs, from where it is carried by the pulmonary veins  to the 
left atrium (pulmonary system). The vascular tree forms a hierarchical system of branched 
arteries and veins that vary in size, mechanical properties, biochemical and cellular content, 
and morphological organization, depending on their location and specific function. Largest 
arteries, such as the aorta, that transport blood away from the heart, branch into smaller 
diameter muscular arteries and then in smaller arterioles and capillaries, which distribute blood 
within the tissues and organs. Blood is returned to the heart through venules, which combine 
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to form small and large veins, which converge in the superior and inferior vena cavae [1]. Blood 
vessels consist of three main layers: the tunica intima, the tunica media, and the tunica 
adventitia. The tunica intima includes the monolayered endothelial lining of the vessel and the 
underlying layer of connective tissue, the internal elastic lamina. The tunica media contains 
concentric sheets of circumferentially aligned smooth muscle cells embedded in a 3-D structure 
of loose connective tissue. The largest arteries (called elastic arteries), such as aorta and 
brachiocephalic have a considerable fraction of elastic tissue, alternated with layers of muscular 
tissue oriented both in longitudinal and circumferential direction. The tunica adventitia, the 
outermost layer of the vessel, contains collagen and a limited number of elastic fibers [2]. 
A number of factors, including, age, genetics, stress, food habits, smoking and alcohol 
consumption are known to contribute to diseases and disorders associated with this system 
which are known as cardiovascular diseases. Nowadays, heart, arteries or veins dysfunctions 
have become the primary cause of death in the USA, the leading causes of mortality in Western 
society [3]. Atherosclerosis is the major disease of blood vessels, and affects the larger and 
medium sized elastic and muscular arteries that contain an intima. It consists of artery wall 
hardening and conduit narrowing (stenosis) through accumulation of fats, cholesterol, calcium 
and other substances in the inner lumen of the blood vessels. The process is commonly referred 
as atherosclerotic plaque formation. The lesions of atherosclerosis takes form of coronary 
artery and peripheral vascular disease, thus leading to ischemia of the heart, brain or peripheral 
organs. World Health Organizations reports that there were at least 7,200,000 deaths due to 
stenosis around the world in 2004 [4].  
 3 
 
1.2 Vascular grafts 
Patients with less severe symptoms are treated with numerous non-invasive 
treatments, such as the use of anti-thrombotic drugs or cholesterol-lowering drugs. Therapies 
such endovascular procedures, are considered available minimally invasive strategies. In the 
case of more severe pathologies, surgical bypass and vessel replacement became necessary. 
Vein replacements have been performed in the largest part with autografts, using healthy 
sections of patient’s own veins. 
In the case of highly compromise arteries, bypass surgery and artery stenting are the 
accepted treatments. Coronary artery bypass grafting or coronary artery stenting are the most 
common diseases for patients with severe artery blockage. Currently, bypass grafts fall in two 
general categories: biological and synthetic grafts.  
1.2.1 Biological grafts 
Biological grafts can be natural veins or minor arteries harvested from the patient itself 
(autograft), from another individual or the same species (allografts or homografts) or from 
animals (xenografts).  
Proposed autologus grafts used in vascular replacement are saphenous veins, internal 
thoracic arteries, radial artery are used. Although vascular bypass grafting remains the gold 
standard for revascularization for ischemic heart disease and peripheral vascular disease, many 
patients do not have healthy suitable vessels, due to previous surgery, vessel diseases or 
trauma. The vascular substitutes have been proposed and tested are decellularized allografts, 
decellularized and cross-linked xerografts and artificial synthetic grafts. 
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1.2.2 Synthetic grafts[5] 
Nowadays, polytetrafluoroethylene (PTFE), Dacron and polyurethane (PU) are 
considered standards materials for vascular replacement. Synthetic polymer devices for 
vascular replacements are the more practical alternative to autografts. Though impressive 
success of these grafts has been made in aortic and iliac surgery (medium and large arteries), 
smaller diameter (≤6mm) grafts has been a symbol for the limitations of modern biotechnology 
because their long-term failure rates are still high [6–8]. Thrombogenicity and graft occlusion 
represent the major limitations for currently used small diameter vascular grafts. The inability 
of the body to remodel synthetic materials is related poor long term patency of permanent 
synthetic grafts. 
. Small-diameter vascular grafts are used as medical implants for a number of diseases, 
such as coronary or periphery artery bypass grafts, pediatric vascular shunts and vascular 
access grafts. The materials and structures of contemporary grafts provide limited capability of 
endothelium regeneration and tissue ingrowth. Lack of good tissue ingrowth and regeneration 
in the grafts makes grafts more prone to ongoing thrombogenity and intima hyperplasia [9–11].  
Exposition of a prosthesis surface to blood flow results rapidly in a deposition of blood 
proteins on the luminal surface and generates the process of platelet activation, leading to 
thrombus formation via the intrinsic coagulation pathway and ultimately in vessel occlusion. At 
the same time, activated platelets secrete platelet-derived growth factor (PDGF), which is 
responsible for the migration of smooth-muscle cells (SMC) from the media into the intima [2].  
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During the past few decades, many efforts have been made to improve the performance 
of vascular grafts mainly through the attempts that modify the structure and surface of the 
contemporary graft materials. These attempts include: (a) increasing structural porosity; (b) 
increasing mechanical compliance; (c) pre-endothelialization; and (d) incorporating anti-
thrombotic molecules on the surface [10,12]. Impressive advancement on these synthetic 
vascular grafts has been made to improve graft patency. However, as commented by Zilla et al 
[8], these graft materials have structure-related limitations to regenerating vascular tissue both 
on the surface and in the transmural space. The non-degradable nature of the materials 
restricts the remodeling and regeneration capability of media and adventitia.  
The most common causes for the poor performance of small-diameter grafts are surface 
thrombogenicity and intimal hyperplasia (IH), which are mainly mediated by denude of 
endothelium and lack of sufficient tissue ingrowth [7,13]. Exposition of a bare graft surface to 
blood flow results rapidly in a deposition of blood proteins on the luminal surface, activating 
platelets and leading to thrombus formation via the intrinsic coagulation pathway and 
ultimately to vessel occlusion. Also, activated platelets secrete molecules such as platelet-
derived growth factor (PDGF) which is responsible for the proliferation and migration of smooth 
muscle cells (SMC) from the media into the intima leading to IH. IH narrows the vessel lumen 
decreasing blood flow to the point that it may in turn promote local thrombosis. Intima 
hyperplasia can also be induced by flow turbulence at the graft-vessel junction due to the 
mismatch mechanical compliance of graft and vessel [14]. Graft modification with protein 
lining, heparin incorporation and polymer resurfacing reduced thrombosis and neo-intimal 
hyperplasia but did little to improve long-term arterial graft patency [9].  
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It is generally agreed that efforts to improve the graft should be made on the formation 
of a physiological vascular tissues including functional endothelium, smooth muscle and 
connective layers around the vascular graft ensure mimetic biological and mechanical 
functioning of the graft and allow it better integrated with native blood vessels [6,8,15]. 
Considering the important role that physiological tissue formation on or around the grafts plays 
in the long-term patency of small-diameter vascular grafts, a more recent research thrust is to 
develop various tissue engineering approaches which allow the tissue formation to 
spontaneously occur in vitro or in vivo and eventually replace the grafts [16,17].  
1.3 Vascular Tissue Engineering approach  
1.3.1 Tissue Engineering 
Tissue Engineering is an interdisciplinary field that applies the principles of engineering 
and life sciences toward the repair and the restoration of damaged tissue functions [18]. The 
three fundamental tools that Tissue Engineering exploits to achieve successful tissue 
regeneration are  cells, scaffolds and specific signalling factors [19]. An effective interplay and 
an synergistic cooperation between these three components have been proven to be a critical 
factors for the process of scaffold-tissue integration and, eventually, for tissue regeneration. 
Scaffolds have to provide adequate structural and mechanical support and to direct cell activity 
toward the regeneration of a new physiological tissue by providing chemical, biological and 
physical cues. For example, active molecules and Growth Factors (GFs), that have the ability to 
influence cell attachment, migration, proliferation and differentiation, can be encapsulated in 
the scaffolds and released in situ [20,21].  
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1.3.2 Vascular Tissue Engineering 
Tissue engineering has emerged as a promising strategy for vascular tissue regeneration. 
Tissue engineering approach aims at regenerating damaged tissues or organs, in order to 
growth an integrated new tissue with the same characteristics of the native one. When in 1986, 
Weinberg and Bell claimed the construction of new blood vessel in vitro, with bovine aortic 
endothelial cells, smooth muscle cells and fibroblasts seeded on a collagen matrix [22] 
[Weinberg and Bell 1986], they signed the road that would address the research strategies for 
tissue regeneration until the present days. This work has been commonly regarded as the first 
engineered construct for vascular tissue engineering, though their work had been published 
seven year in advance to the Tissue Engineering definition [18].Vascular tissue engineering 
offers a promising alternative approach to address the needs for small-diameter vascular grafts 
by overcoming the mechanical and/or biological problems associated with the current materials 
[1]. To avoid adverse hemodynamic conditions, mechanical properties of tissue engineering 
grafts must closely match those of native arteries, meanwhile the grafts should be sufficiently 
strong. Many studies have demonstrated the anisotropic mechanical property of natural 
arteries; higher stiffness in the longitudinal direction can avoid an excessive stimulation of 
anastomotic regions, while being compliant in the circumferential direction to match the 
compliance of native artery can avoid flow disturbance [7,8].  
In vitro tissue regeneration is regarded as the most traditional approach used in the 
studies on tissue engineered vessels. According to the scheme proposed by MacNeill in 2002, 
autologous cells are expanded in vitro and organized on a suitable scaffold, cell culture is 
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performed in specifically designed bioreactors to produce an engineered functional tissue 
similar. The new tissue similar to the physiological one is implanted into the patient, without 
any rejection problem [25]. 
However, expansion of harvested autologous cells in vitro and cell growth onto the 
scaffolds are the time limiting steps. These reasons make this approach barely unfeasible in the 
normal clinical situations, and completely impossible in the case of acute diseases or trauma. 
In the case of in vivo tissue regeneration, a scaffold is directly implanted either in the 
site of injury and the patient’s body itself produces the new tissue, by invading the scaffold with 
cells, remodelling and sometime replacing it in the time.  
1.4 Electrospinning as a method for preparing scaffolds for Tissue 
Engineering 
1.4.1 Electrospinning history 
Electrospinning is the most widely used method to generate nanofibers.  
Fundamental electrospinning idea took its origin from Lord Rayleigh’s observations on 
the electrospray phenomena in 1882 [26]. He found that a highly charged droplet was unstable 
and would break down into smaller droplets in presence of an high voltage: the so called  
“Rayleigh instability’’. The electric Columbic repulsive forces, overcoming the surface tension, 
result in a rupture of the droplet surface. Later, Zeleny investigated the Instability of electrified 
of aqueous solutions [27]; in the late 60’s, Dole et al. studied the electrosprays of dilute 
polymer solutions [28]. Electrospinning phenomenon is a similar to the electrospraying; the 
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substantial difference between the two is that electrospinning produces continuous fibers 
instead of small droplets.  
In 1934, Formhals electrospun fine fibers from a cellulose acetate solution and 
registered a patent in U.S. on this new technology [29], [30]. Later, Simons signed another 
patent, in which he used concentrated solutions to increase the viscosity, having a more stable 
process and producing longer fibers [31]. In the early 80’s, Larrondo and Manley performed an 
electrospinning process with polymer melts and produced polyethylene nanofibers [32].  
The recent, rising interest in nanotechnology has renewed attention to this convenient, 
economical technology that enables engineers to produce nanofibers for various applications. 
1.4.2 Electrospinning process 
The electrospinning process enables to produce polymeric fibers with diameters in the 
range of a few nanometers to several microns. In electrospinning, a high voltage is applied to 
polymer solution (or a melt), saturating the solution with electrical unbalanced charges. The 
polymeric solution is stored in a reservoir and is forced out of a needle (or spinneret) at a 
constant rate. With increasing voltage, the surface charge on the polymer droplet increases, 
resulting in the formation of a conical shape (Taylor cone) at the tip of the spinnaret. As shown 
in Figure 1-1, once that a threshold voltage has been reached, the surface charge overcomes 
the surface tension and viscosity of the polymer droplet, a jet is initiated and ejected form the 
apex of the Taylor cone toward the grounded collector. 
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Figure 1-1. Schematization of the electrospinning process 
The jet travels toward a region of lower electrical potential, that, for convenience, is a 
grounded collector. After being ejected from the apex of the Taylor cone, the jet travels linearly 
in a region, called linear region, whose extension can vary considerably between different 
polymer/solvent system. After that the high charge density results in a instability of the jet, that 
enters a so called instability region, where it undergoes to repeating bending and whipping 
rapid movements that contributed to elongate the fiber, narrowing its diameter down to the 
nanometric range. High speed photography have been used to image the fiber path and 
behavior along the air gap between spinneret and collector [33,34]. In addition. several studies 
applied mathematical models and numerical simulations to rationalize the shape of fiber track 
and the bending instability phenomenon [33,35,36].  
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In the small fraction of time, in which the jet travels from the needle to the grounded 
collector, the solvent evaporates, and dry nanometric fibers are deposited on the metal target 
plate, forming a non-woven nanofibrous mat. A fundamental step by step description of the 
electrospinning principles and the mechanisms of fiber formation have been presented by 
Rutledge and Fridrikh [37], and Detailed reviews on the topic of electrospinning for tissue 
engineering are given by several groups [35,38–41]. The electrospinning process can be 
manipulated by a number of variables for desired morphology and property of nanofibers. 
These variables include solution characteristics, process variables, and environmental 
parameters. Polymer solution characteristics, such as polymer molecular weight, concentration, 
solution viscosity, solution charge density, conductivity, dielectric constant and surface tension, 
are often difficult to isolate since varying one generally affects others. Process or system 
variables include: 
• flow rate, 
• field voltage,  
• distance between tip and collector,  
• needle tip design and placement,  
• collector composition and geometry.  
 
Environmental parameters, such as environmental temperature, humidity and 
atmosphere, are as important but less often explored [42], [43]. A general understanding of 
these parameters, allows one to set up a process to produce defect-free fibers with controllable 
nanofiber morphology. When electrospinning parameters are optimized, the obtained fiber 
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diameters should have a narrow distribution. Also, porosity of electrospun materials can be 
altered by changing the void spaces laying between the fibers through varying the mean fiber 
diameter, the diameter distribution and the degree of fiber packing.  
1.4.3 Electrospinning in Tissue Engineering 
Electrospinning is a simple and widespread technique for the production of nano- and 
micro-metric polymeric fibers that are deposited on a grounded collector to form a nonwoven 
material with regular nano-structured surface [44]. Electrospun nanofiber matrices are 
characterized by ultrafine continuous fibers, interconnected pores, high porosity and variable 
pore-size distribution similar to the dimensions of basement membranes. Those matrices 
present a dynamic system in which the pore size and shape can change when compared to 
other rigid porous structures. 
Electrospun constructs can be produced that are particularly interesting as scaffolds for 
Tissue Engineering and as drug delivery systems [45–49]. A variety of degradable and 
resorbable materials have been processed, including degradable polyesters, such as poly(ε-
caprolactone) (PCL), poly(lactide) (PLA), poly(glycolide) (PGA) and their copolymers poly(lactide-
co-glycolide) (PLGA) , and natural polymers, such as collagen, silk fibroin, fibrinogen and other 
proteins [50–54].  
Electrospun devices have been proposed for a multiplicity of applications where the 
scaffold is required to interact with different cells, tissues or even different organs at the same 
time.  In those situations, the electrospun scaffold acts like an interphase between 
environments with diverse characteristics and requirements. For example, electrospinning have 
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been considered in the repair of the osteochondral defects, where integration with both the 
subchondral bone and the deep cartilage zone is required. The two regions are characterized by 
different cell types, different degree of vascularisation of the tissue, collagen distribution and 
porosity. Therefore, a scaffold with the ability to interact independently with the two tissues, in 
a particular selectively release different biomolecules, is required [Yang, engineering 
orthopaedic interfaces]. In the field of tissue engineered vascular grafts electrospun scaffold 
have been used to promote endothelial call attachment and proliferation on one side, while 
supporting the organization of new extracellular matrix generated by smooth muscle cells and 
fibroblasts on the other side. Selective release of Growth Factors that could target specifically  
the different types of cells has been prospected both for in vitro co-culture tests and for in vivo 
integration of tissue engineered vascular grafts. Control- and spatial-confinement of the 
released biomolecules can be obtained with graded materials and segregation of the delivery 
systems in particular regions of the scaffold. 
1.4.3.1 Nanofibers scaffolds 
Scaffolds made from nanofibrous materials using electrospinning techniques have been 
increasingly used for various tissue constructs, including those for replacement of intervertebral 
disk, meniscus, annulus fibrosus, blood vessels, and cartilage [55–61]. The advantages of using 
nanofibrous scaffolds for tissue engineering include their load-bearing functionality, porous 
structure, and nano- to micro- sized fibers, similar in the length scale to native extracellular 
matrix (ECM), to guide cell adhesion and proliferation [53,54,62–65]. The versatile use of 
electrospinning with a variety of natural and synthetic degradable polymers offers a large 
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repertoire for tissue engineering and drug delivery applications [66–69]. Additionally, 
electrospun biomaterials provide a wide range of mechanical and chemical properties via fiber 
composition, diameter, distribution and porosity, through control over a panel of engineering 
parameters in the process [45,47,49,70]. Further, collection of nanofibers onto a rotating 
mandrel or other collectors with specialized surfaces, can result in structural and mechanical 
anisotropy for the applications of vascular or fibrous tissue engineering [43,71].  
1.4.3.2 Nanofibers scaffolds for vascular Tissue Engineering 
Recent developments in nanofiber fabrication technology provide tremendous 
opportunities to improve vascular implant performances, because diverse fabrication methods 
and functionalization strategies allow one to design optimal material properties and 
environments for desired short-term and long-term performances that meet the needs of a 
specific treatment [72–75]. Specifically, nanofiber scaffolding materials offer a number of 
advantages for vascular grafting applications:  
The nanofibers mimic the nanostructure of the extracellular matrix (ECM) of natural 
tissues. Cells live in a nano-featured ECM environment. They attach and organize better around 
fibers with diameters much smaller than cell diameter (>5μm). It is found that nanometric 
surface topography with a high surface area-to-volume ratio attracts more endothelial cells and 
promote their growth, thus, accelerating the re-formation of an endothelium to prohibit 
thrombosis of the artery [76].  
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Controllable porosity and interconnected pores together with biodegradable property 
could allow the materials to have large and ever increasing space for SMCs to grow, migrate 
and fulfill regeneration and for better integration of the host tissue in the long term.  
Electrospinning of synthetic fibers and protein fibers have been demonstrated for 
vascular applications. Electrospun synthetic polymers such as PCL and PLGA have successfully 
been applied to engineer vascular tissues [50–52,77,78]. Electrospinning of natural-derived 
biopolymers such as collagen, elastin, silk fibroin, chitosan and fibrinogen have also been 
developed for vascular engineering [79–81].  
A particularly interesting and promising area of electrospinning is creating composite 
scaffolds with mixed nanofibers or with a blended composition of polymers in the nanofiber. 
The benefit of scaffolds formed with a combination of different polymers is in the possibility of 
synergizing the favorable characteristics of each individual component to obtain a composite 
with superior mechanical and/or biological properties required for vascular grafts. Nanofibers 
with different physical or biological properties, such as hydrophobic/hydrophilic fibers, fibers 
with different degradation rates, and synthetic/biological fibers, can be combined to form 
hybrid fibers with desired properties. The hydrophilic/hydrophobic characteristic is a critical 
factor that affects protein adhesion thus influencing blot clotting formation and cell adhesion. It 
also affects biomolecule release and mechanical properties. Therefore, a composite made of 
hydrophobic and hydrophilic polymers can combine superior mechanical properties, better 
hydrolytic resistance and better thrombo-resistance that hydrophobic polymers provide with 
higher molecule incorporation potential that hydrophilic polymers provide [81]. Using fiber 
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composites with a polymer that degrades faster than the other can increase the porosity for 
tissue in-growth [82].  
1.5 Drug delivering scaffolds for tissue regeneration 
In addition to structural support, mechanical property and biodegradable feature, an 
ideal scaffold for tissue regeneration should provide molecular cues to guide regeneration of 
tissue structure and function. To incorporate regenerative or therapeutic molecules into 
biomaterials that sustain the molecule release in vitro or in vivo, various methods such as 
adsorption and covalent binding [83,84], encapsulation [85,86], and addition during scaffold 
formation [87], have been developed. A step forward could be moving from static cues of one 
molecule toward delivery systems that reproduce more closely the dynamically evolving 
microenvironment occurring in natural ECM [88–90]. The delivery systems incorporating 
molecules, mainly biodegradable particles, could offer distinctive advantages such as regulation 
of release rate while protecting their molecule cargo during all the stages of tissue regrowth 
[91,92]. Indeed, scaffolds that support tissue repair, regrowth or regeneration from cells, 
particularly from undifferentiated stem or progenitor cells, may have to partially recapitulate 
natural tissue morphogenesis, which is driven by the concomitant action of multiple factors 
working in concert. Growing evidence has shown that tissue morphogenesis is coordinated by 
the spatial arrangement and temporal duration of multiple molecules in the three-dimensional 
(3D) ECM [93,94]. For precise regulation, recent developments have demonstrated the benefits 
of using micro- and nano- structures [70,95–104]. The majority of newly-developed molecule-
impregnated scaffolds, however, are capable of achieving sustained or temporally-controlled 
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molecule release. Few techniques are available to engineer 3D scaffolds that define spatial 
organization of molecules or control release in both space and time scale. Control of where and 
when a molecule acts can strongly contribute to provide spatially complex arrangements of 
cells in length scales ranging from nano-/micro- meters to centimeters. The spatial control over 
release is critical to coordinate cell behaviors for tissue pattern formation[92,102]. Selective 
release of molecules that target specific cell types or tissue formation without influencing the 
activity of other cell populations or tissue functions is important to establish both in vitro 
physiological tissue models and in vivo tissue regeneration [105–107]. Patterning or segregation 
of molecule delivery materials are important to spatially confine biomolecules [108–110]. To 
meet various physiological needs of different cell types during tissue regrowth, a 3D scaffold 
should present a multitude of regenerative biomolecules in a sustained manner at defined 
locations. 
1.5.1 Nanofibers scaffolds as drug delivery systems 
Recently, strategies that use electrospun fibers to encapsulate and deliver molecules 
have been established [46,87,104]. Due to inherently high surface area of electrospun 
materials, nanofiber constructs allow high molecule loading and efficient release in situ. 
However, the developed techniques have been limited to tune molecule release kinetics and 
often the structure and property of nanofibers are significantly influenced to facilitate molecule 
encapsulation. Herein, we report a new strategy of designing electrospun constructs, which 
utilize micropatterns of nanofiber to spatially define or temporally control delivery of 
molecules. We previously demonstrated the development of double-electrospinning system 
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that used a rotating mandrel collector to produce constructs composed of interpenetrating 
networks of nanofibers with diverse nanofibers in a tailored proportion to achieve anisotropic 
mechanical properties and engineered surfaces [43]. The incorporation of molecules which 
affect cell function and tissue regeneration must be designed to target at specific cell 
physiology process, dependent on cell type and cell differentiating state. Thus, an in-depth 
understanding of vascular cell biology and/or stem cell biology, particularly cell signalling, is 
important for the incorporation of the right molecular signals at the right location and time. 
Localized delivery of medicaments at a controlled rate over a specific period of time improves 
therapeutic efficacy and reduce toxicity of bioactive agents. In this view, a finely designed 
controlled-release device is required to spatially and temporally encounter the needs of the 
regenerating tissue [102,111,112]. 
1.6 Objectives of the thesis 
Designing bioinspired vascular grafting materials through nanofiber fabrication 
techniques, such as electrospinning is an emerging field. To enhance the biomimicry of 
nanofibrous scaffolds, multi-functional nanofibers should be made by combining bioactive 
surface with spatiotemporal release of functional molecules and drugs. This is being explored 
by following techniques: (a) modifying the surface of nanofibers; (b) incorporating bioactive 
molecules in the nanofibers and achieving spatiotemporal control over the molecule release; (c) 
incorporating cells during the fiber-formation process; and (d) forming composite nanofibers 
that combine the different mechanical, bioactive and degradable properties of component 
materials. 
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The objective of this thesis is to develop a platform for producing a novel and innovative 
scaffolds for Vascular Tissue Engineering applications. Vascular tissue engineering offers a 
promising alternative approach to address the needs for small-diameter vascular grafts by 
overcoming the mechanical and/or biological problems associated with the current synthetic 
materials. The primary requirement is to design and manufacture with adequate mechanical 
property and deformational behavior and superior surface biocompatibility for endothelial cell 
adhesion and proliferation. To overcome the drawbacks related to materials and structures 
used in contemporary synthetic grafts, we will combine the superior biological properties of a 
natural polymer (silk fibroin) with higher mechanical stability and performance of a degradable 
and resorbable polyester (PCL). In Chapter 2, we will demonstrate a robust multilayered 
scaffolds with intermixing nanofiber structure, tunable anisotropy ratio, and surface properties 
which may hold great potential in tissue engineering applications.  
Moreover, the present study intends to address the problem of spatial confinement of 
drug delivery in a specific region of the scaffold. Therefore, we will design scaffolds with 
capability of selectively releasing molecules in spatially- and temporally- controlled manner. 
Herein, electrospun composite scaffolds used to form materials with compositional and 
biochemical gradients along the scaffold thickness will be presented in Chapter 3, Chapter 4 
and Chapter 5. We have characterized compositional and morphological changes as well as 
degradation behaviours of these composite scaffolds. More importantly, we will display a 
variety of tunable nanofiber micropatterns composed of degradable polymers PCL and PLGA 
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and characterized by compositional and biochemical gradients with the ability to control 
spatially and temporally the delivery of one or multiple molecules.  
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2 BIOHYBRID NANOFIBER COMPOSITE CONSTRUCTS 
WITH ANISOTROPIC MECHANICAL PROPERTIES 
 
Abstract 
 
Synthetic implant materials often lack of the anisotropic mechanical properties and cell-
interactive surface which are shown by natural tissues. For example, engineered vascular grafts 
need to be developed to address the mechanical and biological problems associated with the 
graft materials. The present study has demonstrated a double-electrospinning fabrication 
process to produce a poly(ε-caprolactone)-fibroin multilayer scaffold which shows well-
integrated nanofibrous structure, endothelial-conducive surface and anisotropic mechanical 
property, suitable as engineered vascular constructs. Electrospinning parameters such as 
voltage, solution concentration, feed rate and relative humidity were optimized to obtain 
defect-free, uniform nanofibers. In order to mimic the different mechanical properties of 
natural vessels in the circumferential and longitudinal directions, a rotating cylinder was used 
as collector, resulting in the production of constructs with anisotropic properties. The 
combination of the collector shape and the collector rotation allows us to produce a tubular 
structure with tunable anisotropic mechanical properties. Fourier transform infrared 
 22 
 
spectroscopy, differential scanning calorimetry and uniaxial tensile tests were used to 
characterize the electrospun constructs. Cell cultures with primary endothelial cells 
demonstrated that cells showed spread morphology and strong adhesion on fibroin richer 
surfaces. The platform for producing robust multilayer scaffolds with intermixing nanofiber 
structure, tunable anisotropy ratio, and surface with specific compositions may hold great 
potential in tissue engineering applications. 
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2.1 Introduction 
The proper design of a scaffold that supports tissue regeneration has to take in account 
for a variety of factors such as mechanical properties, surface properties, morphology, pore size 
and distribution, biocompatibility and biodegradability [1,2]. Mechanical properties on tissue 
regeneration and cell growth are particularly important in tissues such as bone, muscles, 
cartilage, blood vessels and tendons [115].  
Vascular grafts are currently used to replace damaged or occluded blood vessels for 
treatment of a number of vascular diseases such as coronary vascular diseases. Many patients 
that require vascular grafting do not have suitable autologous grafts and thus require synthetic 
grafts. Synthetic vascular grafting materials currently in clinical use are often made from stiff, 
bioinert materials such as expanded polytetrafluoroethylene (ePTFE) and dacron. When these 
synthetic grafts are used to replace small-diameter (<6 mm) vessels, low patency or high failure 
rates occur [116].
. 
Grafting pathology is often characterized by anastomotic intimal hyperplasia 
and thrombosis, which are induced by improper hemodynamic, inflammatory or coagulatory 
conditions around grafts. A leading cause of these adverse conditions is the mechanical and 
biological properties of the synthetic graft materials [8].  
Vascular tissue engineering offers a promising alternative approach to address the 
needs for small-diameter vascular grafts by overcoming the mechanical and/or biological 
problems associated with the current materials [1]. To avoid adverse hemodynamic conditions, 
mechanical properties of tissue engineering grafts must closely match those of native arteries, 
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meanwhile the grafts should be sufficiently strong. Many studies have demonstrated the 
anisotropic mechanical property of natural arteries; higher stiffness in the longitudinal direction 
can avoid an excessive stimulation of anastomotic regions, while being compliant in the 
circumferential direction to match the compliance of native artery can avoid flow disturbance 
[23,24].  
Therefore, one of the goals in the present study is to create a structure that reproduces 
anisotropic mechanical properties of natural arteries. In addition, to provide anti-coagulatory 
and anti-inflammatory environments, the graft surface must be inherently anti-thrombogenic 
or conducive to endothelial cells. Furthermore, the presence of non-degradable grafts always 
imposes long-term concerns about the synthetic materials. Therefore, an ideal tissue 
engineering graft scaffold should not only closely match the mechanical properties of native 
arteries and be conductive to endothelial cells, but also be degradable as it provides a 
temporary scaffold to support the growing tissue substitute until cells produce their own 
extracellular matrix. It has been shown that a single material is difficult to simultaneously 
satisfy all these requirements.   
Electrospinning is an attractive technique for fabricating tissue engineering scaffolds, 
due to the simplicity of the process and the capability of generating nanofibrous structures that 
mimic the natural extracellular matrix [40,45,117]. A variety of polymers have been electrospun 
for biomedical applications proposed in a wide range of areas including skin, nerve, tendon, 
cartilage, bone, and blood vessel [118–120]. Regenerated silk fibroin, one of the most 
promising biological polymers, is recently experimented in the field of tissue engineering 
because of its favorable interactions with cells and proteins [121–123]. Zhang et al. suggested 
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that electrospun fibroin scaffolds held potential for explorations of tissue-engineered vascular 
grafts because they sustained vascular cell viability, maintained cell phenotype and promoted 
cell reorganization [124]. In a recent study, Bondar et al. [125] have shown that endothelial cells 
recognize fibroin nanofibers through integrin-dependent mechanisms and, and the nanometric 
silk fibroin scaffolds did not interfere with the formation of a differentiated and interconnected 
endothelial layer. Poly(ε-caprolactone) (PCL) is a semicrystalline, bioresorbable, aliphatic 
synthetic polyester. A number of implantable medical devices are made of robust PCL. 
Electrospun PCL materials have been widely demonstrated for biomedical applications [126–
128].  
In the present study, we have demonstrated a novel multilayered biohybrid nanofiber 
scaffold made of silk fibroin and PCL. The scaffold is characterized by anisotropic mechanical 
properties, surface conducive to endothelial cells and degradation capacity. Anisotropic 
mechanical properties and surfaces with different functionalities are achieved by sequentially 
and simultaneously electrospinning fibroin and PCL on a rotational mandrel, which forms a 
robust multilayered structure with non-homogeneous compositions and an interpenetrating 
fibrous layer in the transition region. 
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2.2 Materials and Methods 
2.2.1  Materials 
Cocoons of Bombyx mori silkworm PN06 (Poli-ibrido Nazionale 2006) were kindly 
supplied by Centro Sperimentale di Gelsibachicoltura (Como, Italy). Poly-ε-caprolactone (PCL) 
with nominal average MW of 80,000 Da and poly(ethylene oxide) (PEO) with nominal average 
MW of 500,000 Da were purchased from Sigma Aldrich S.r.l (Milan, ITALY). Formic acid (98-
100% purity) was also obtained from Sigma-Aldrich. N,N-dimethylformamide (DMF) minimum 
purity 99.9%, and methylene chloride (DCM)  minimum purity of 99.5% were purchased from 
BDH Italia (Milan, Italy). All other substances were of analytical or pharmaceutical grade and 
obtained from Sigma-Aldric. 
2.2.2 Preparation of regenerated Bombyx mori silk fibroin 
Bombyx mori silk-fibroin water solutions were prepared as previously described [129]. 
Briefly, to remove sericin, cocoons were degummed by treating silk twice with 1.1 g/l and 0.4g/l 
Na2CO3 (anhydrous, minimum 99%) water solution at 98 °C for 1 hr each time. This resulted in 1 
litre of solution containing 10 g of silk fibroin, which were then washed in de-ionized water and 
air-dried. The extracted silk fibroin was then dissolved in 9.3M LiBr (1 g fibroin in 10 ml LiBr 
solution) at 65 °C for 8-10 hr. After that, the solution was dialyzed in a Slide-A-Lyzer Cassette of 
3500 MW (Pierce, Rockford, Illinoys, USA) against distilled water for three days in order to 
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remove the salt, and then filtered through a ceramic filter foam (porosity <5 μm). Finally, 
water-soluble powders of fibroin were prepared with a freeze-drying process. 
2.2.3  Electrospinning 
2.2.3.1 Preparation of spinning solutions 
A series of fibroin solutions were prepared by dissolving regenerated silk-fibroin 
powders in formic acid at a concentration of 8-16% (wt%). PCL was dissolved at a concentration 
of 9% (wt%) in a mixture of DCM/DMF with 3-to-1 volumetric proportion. PEO was dissolved at 
a concentration of 5% (wt%) in water.  
2.2.3.2 Electrospinning of single-polymer materials 
In this study, single-polymer materials and composite materials were produced in flat 
sheet form or in tubular shape. The single-polymer nanofibrous materials were fabricated by a 
single electrospinning apparatus. A home-made electrospinning apparatus was composed of a 
Gamma High Voltage Research ES30P-10W power supply (Gamma High Voltage Research Inc., 
Ormond Beach, FL), a single syringe pump (Pump 11 Plus - Harvard Apparatus, Crisel 
Instrument, Rome, ITALY), and a flat aluminium collector to produce flat sheets or a rotating 
cylindrical collector to produce tubular-shaped materials. A cylindrical collector with 20 mm in 
diameter was rotated by a brushless rotating electric motor (BLF230C-A Oriental Motor Italia 
S.r.l., Milan, ITALY). Rotation speeds in the range of 50 - 2000 rpm were achieved. In addition. 
another collector with 4.96 mm in diameter rotating at 100 rpm was used to produce 
constructs with a smaller diameter. To facilitate the detachment of the scaffold materials 
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(fibroin or PCL), the collector was preventively coated with a thin veil of electrospun PEO. 
Fibroin and PCL fibers were collected with needle-collector distances of 12 cm and 22 cm, 
respectively. Syringes of 5 ml were filled with polymer solutions and fitted with a stainless-steel 
18G blunt-ended needle which is then connected to 25 cm flexible PTFE tubing.  
2.2.3.3 Parametric study in the fibroin electrospinning process   
To produce good-quality silk-fibroin nanofibers, several electrospinning parameters 
were investigated and analyses were carried out on evaluating their effects on fiber 
morphology and diameter. The parameters of interest included applied voltage, solution 
concentration and feed rate, which varied in the range of 14-30 kV, 8-12% (wt%) and 1-12 
μl/min, respectively. In addition, the effect of environmental relative humidity on fiber 
diameter was investigated. The electrospinning processes were thus carried out in two different 
environments with a relative humidity of 45% or 70%. Parameter configurations that resulted in 
defect-free fibers were carried further for morphology, chemical and thermal characterizations.  
2.2.3.4 Double-electrospinning system to produce nanofibrous composite scaffolds 
 Multilayered composite scaffolds were produced by a new double-electrospinning 
system (Figure 2-1a and Figure 2-1b) through sequentially and simultaneously electrospinning 
fibroin and PCL on a rotational mandrel collector.  
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a. 
 
b. 
 
c. 
Figure 2-1. (a) Schematic illustration of the double electrospinning system; (b) Actual setup of 
the system; (c) Illustration of the PCL_fibroin multilayered material. 
In sequence, a thin layer of fibroin nanofibers, an intermixed layer of fibroin and PCL 
nanofibers, and a thick layer of PCL electrospun fibers were deposited on the grounded 
cylindrical metallic collector (Figure 2-1c). Each solution (fibroin or PCL solution) was stored in a 
separate 5 ml syringe that served as a charged spinneret. The syringe was fitted with a blunt-
ended needle and connected to PTFE tubing. Each spinneret were placed at the opposite side of 
the rotating mandrel, perpendicularly oriented with respect to the principal axis of the 
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collector, and connected to a separate high voltage power supply. Both spinnerets moved in 
concert over a 15 cm path with a speed of 5m/s along the mandrel under the control of a linear 
motorized stage (EZS3D025-C  Oriental Motor Italia S.r.l., Milan, ITALY). The feed rates of the 
two solutions were varied independently between 0 and an optimal flow rate over the 
deposition time via two different syringe pumps. 
Using single-polymer electrospinning processes, electrospinning parameters were 
optimized for regenerated fibroin and PCL (Table 2-1).  
 
Parameter Fibroin PCL 
Solvent  
Concentration 
Voltage 
Work distance 
Feed rate 
Formic acid 
10% (wt)   
22 kV 
12 cm 
7 μl/min 
DCM/DMF (3:1) 
9% (wt) 
28 kV 
22 cm 
15 μl/min 
Table 2-1. Optimized electrospinning parameters. 
These fabrication parameters were used to produce fibroin-PCL composite scaffolds. 
Using the double electrospinning system described above, the silk-fibroin solution stored in 
syringe A was first electrospun on the collector at a feed rate equal to the optimal value of 
7μl/min, while the PCL solution stored in syringe B were kept static. Thus, a thin layer of fibroin 
nanofibers was obtained. After 5 minutes, the PCL solution started to be electrospun and 
deposited onto the collector with a low feed rate of 1 μl/min. This was done simultaneously 
with the electrospinning and deposition of fibroin. During the next 10 minutes, the feed rate of 
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the PCL solution was gradually adjusted to the optimal value of 15μl/min, while the feed rate of 
the fibroin solution were gradually reduced to zero. As a result, an intermixed interlayer of 
fibroin and PCL nanofibers was deposited on the top of the thin fibroin layer (Figure 1b). Finally, 
electrospinning of the PCL solution was conducted for another 30-40 minutes, in order to 
obtain a thick PCL bulk layer. The obtained electrospun tubular constructs were cut along the 
longitudinal axis, resulting in a smooth flat sheet with a dimension of 6x12 cm and thickness 
approximately in the range of 90-120 μm. 
2.2.3.5 Post-treatment of scaffold materials containing fibroin 
A water/methanol mixture with 9:1 ratio was used for fibroin stabilization and 
detachment by dissolving PEO. Then, fibroin was rinsed with DI water and soaked overnight in 
DI water to eliminate solvent residuals. 
2.2.4  Characterizations of the scaffold materials 
Non-woven electrospun meshes were imaged with scanning electron microscopy (SEM). 
To investigate net morphology, samples were mounted on aluminium stubs and sputter coated 
with gold. Observations were made at 10 kV by using a Stereoscan 200 SEM (Cambridge 
Instrument Company, Cambridge U.K.). For nanofiber diameter analysis, three images were 
taken in different locations of each sample, and roughly 100 fiber diameters were measured 
and averaged using Image-J, an image analysis software. Results were presented as mean ± 
standard deviation. 
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Electrospun mats were analysed by FTIR in attenuate total reflectance (ATR) mode with 
a Perkin Elmer Spectrum One Spectrophotometer equipped with a diamond probe. In all cases 
64 scans at a resolution of 2 cm
-1
 were used to obtain the spectra. 
Differential scanning calorimetry (DSC) was performed on 10 mg of material in an open 
crucible. The analysis was performed with a TA2920 calorimeter under flushing nitrogen (100 
ml /min). A sample was first cooled down to -100 °C at the cooling rate of 50 °C/min, and was 
held at this temperature for 5 min. Subsequently, the first scan was performed by heating the 
sample up to 100 °C with the heating rate of 10 °C/min. This was followed by quenching the 
sample to -100 °C. The second heating scan was carried out by heating the sample from -100 to 
315 °C with the heating rate of 10 °C/min and obtaining the thermogram. The melting peaks of 
PCL and PCL/fibroin samples were quantified by integration. Degree of crystallinity χc of PCL 
was calculated using χc = 100*ΔHm/ΔHm°, where ΔHm° was the theoretical heat of fusion for 
PCL  with 100% crystallinity equal to 135 J/g. 
2.2.5 Mechanical characterization 
Mechanical properties were evaluated with uniaxial tensile tests on rectangular 
specimens (30x5 mm and 15x3 mm) cut along the circumferential (or transversal) direction and 
the longitudinal direction. Silk-fibroin nets were tested in a wet condition as well as in a dry 
condition. The fibroin nets were stored in water for 3 days at 4 °C before testing. For each 
specimen, three thickness measurements were taken using an electronic digital micrometer 
and averaged; three width measurements were taken using a custom digital caliper and 
averaged. Thickness of the specimens was in the range of 40-50 μm for fibroin electrospun 
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mats and 100-120 μm for PCL and composite samples. Mechanical tests were performed with 
an electromechanical Instron 4502 (Instrom, Canton, MA) universal tensile testing machine 
equipped with a 100 N load cell. Samples were first preloaded to 0.10 N, and the gauge length 
was recorded. The tensile test was carried to failure at a rate of 3 mm/min for fibroin samples 
and 10 mm/min for PCL samples and multilayered samples. Elastic modulus was calculated 
from the slope of the linear portion of the resultant stress-strain curve; maximum stress and 
failure deformation were also calculated from the measurement data. Four to five specimens 
were tested for each sample. The calculated values were averaged and reported as mean ± 
standard deviation. Students’ t-test was carried out for statistic analysis of the data. A p value 
less than 0.05 was considered statistically different; a p value less than 0.01 was considered 
statistically very different.   
2.2.6 Cell characterization   
The endothelial cells used for characterization were cells isolated from proximal bovine 
pulmonary arteries and sub-cultured. Cells between passages three and six were used. Cells 
were cultured in Dulbecco’s Modified Eagle’s Medium (from Sigma-Aldrich) supplemented with 
10% FBS, 2% L-Glutamine, and 1% penicillin-streptomycin at 37 ˚C and 5% CO2 in the cell culture 
incubator. Circular electrospun nets (diameter of 1.5 cm) were sterilized in 70% ethanol, 
allowed to dry and briefly exposed to UV light before seeding. Cells were cultured to 90% 
confluency in the culture flask, detached and then seeded on the fibroin side with 1.0 ml of cell 
suspension per membrane at the concentration of  200,000 cells/ml. Culture medium was 
changed every other day. After 4 days of culture, the cell-seeded membranes were fixed with 
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4% formalin and stored in PBS at 4 °C. In order to prepare samples for SEM examination, 
electrospun nets were washed 2–3 times with distilled water, exposed to different grades of 
ethanol for 10 min. Finally, they were air dried under laminar flow hood. Samples were sputter 
coated with gold and the morphology was observed under SEM (JEOL 6480LV) at an 
accelerating voltage of 10 kV. 
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2.3 Results 
2.3.1  Fibroin and PCL electrospun materials produced by a single-polymer 
electrospinning process 
We have established single-polymer electrospinning processes to fabricate nanofibrous 
materials made of fibroin and PCL, respectively. The process parameters for each type of 
material have been optimized using a flat collector in the electrospinning system, and results 
are listed in Table 1. SEM images (Figure 2-2) demonstrate the microscopic morphology of 
nanofibrous fibroin nets and PCL nets electrospun with the optimized parameters. In both nets, 
the nanofibers appear to have a rounded cross-section and regular shape, with diameters in the 
nanometric range.  
The average diameters of fibroin and PCL nanofibers are 192±79 nm and 421±105 nm, 
respectively. Because several studies have reported the electrospinning process of PCL 
structures [130], [78], the optimization of PCL electrospinning parameters is not detailed here. 
Parametric studies on the fibroin electrospinning process are presented below because of its 
unique setup. In addition, using a rotational cylindrical mandrel, we have developed the 
electrospinning processes for tubular structured fibroin and PCL, respectively. Parametric 
studies for these electrospinning processes, in particular, the effects of rotation speed on 
anisotropic mechanical properties of PCL nets and silk-fibroin nets, respectively, are presented.  
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Figure 2-2. SEM imaging graphs of silk-fibroin nanofibers (a) and PCL nanofibers (b) (scale 
bar = 10 μm). At a higher magnification, details of fiber morphology are shown (scale bar = 3 
μm). The electrospinning processes were conducted on a flat aluminium collector with RH = 
70% and optimized electrospinning parameters listed in Table 1. 
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2.3.1.1 Fibroin nets: parametric studies on nanofiber diameter 
Four electrospinning parameters, namely voltage, solution concentration, feed rate and 
relatively humidity, have been varied to investigate their influences on the fibroin fiber 
diameter. The electrospun fibers usually show diameters ranging from tens of nanometers to 
one micron. It is found that applied electric voltage in the tested range does not significantly 
influence the diameter of silk-fibroin nanofibers (Figure 2-3a), while the solution concentration 
plays an important role in determining the fiber diameter. No continuous defect-free fibers 
have been obtained with the fibroin solution at a concentration of 8% or lower in formic acid. 
When the solution concentration is 10% or higher, the mean fiber diameter increase 
exponentially with concentration; the mean fiber diameter increases from 192 nm at 10% to 
325 nm at 14% (Figure 2-3b).  
With our fabrication setup, it is not possible to obtain fibroin solutions in formic acid at 
a concentration higher than 14%. Another parameter, the feed rate at which the solution is 
forced out of the spinneret, does not significantly influence the mean fiber diameter when the 
feed rate is lower than 7 μl/min. Higher feed rates result in larger mean diameters (Figure 2-3c). 
Furthermore, environmental relative humidity (RH) shows a significant effect on the fiber 
diameter (Figure 2-3d). Electrospinning in a relatively humid condition (RH = 70%) results in 
much larger fibroin fibers compared to that in a less humid condition (RH = 45%).  
 38 
 
 
0
100
200
300
12 14 16 18 20 22 24 26 28 30
Voltage [kV]
Fi
be
r 
D
ia
m
et
er
 
[n
m
]
FA fib 10%
 
a.  
y = 112.74e0.2637x
R2 = 0.9993
0
100
200
300
400
500
8 10 12 14 16
Concentration [%]
Fi
be
r 
Di
am
et
er
 
[n
m
]
FA fib 22kV
 
b. 
0
150
300
450
0 3 6 9 12 15 18
Feed rate [µl/min]
Fi
be
r 
Di
am
et
e
r 
[n
m
]
 
c. 
0
100
200
300
400
20 24 28
Voltage [kV]
Fi
be
r 
D
ia
m
et
e
r 
[n
m
]
R.H. 70%
R.H. 45% 
 
d. 
Figure 2-3. Effects of electrospinning process parameters on the mean fiber diameter of 
electrospun silk-fibroin: (a) applied voltage; (b) solution concentration; (c) feed rate; and (d) 
environmental relative humidity (R.H.). Effects of R.H were studied at different 
electrospinning voltages: 20 kV, 24 kV, and 28 kV. 
Using the single-polymer electrospinning process with optimized parameters (Table 2-1) 
and a flat collector, fibroin nanofibers are characterized by an average diameter of 192 nm with 
a narrow normal-like distribution (Figure 2-4). The resultant electrospun nets contained a 
uniform array of randomly oriented fibers with smooth rounded surface. 
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Figure 2-4. Frequency distribution of the fiber diameter of silk-fibroin nets electrospun with 
optimized parameters shown in Table 2-1. 
2.3.1.2 Fibroin nets: mechanical properties in a hydrated condition 
Fibroin nanofiber scaffolds were prepared by electrospinning fibers on a rotating 
cylindrical collector with a 20 mm diameter at varied rotation speeds including 100, 250, 500, 
1000, 1500 and 2000 rpm. As a reference, electrospun samples for 0 rpm were prepared by 
using a rectangular collector with the same projected area as the cylindrical collector. Tensile 
tests were performed on the samples cut from the tubular constructs in the longitudinal 
direction and in the circumferential direction, respectively. Samples of a similar size from the 
rectangular scaffold materials were used as the reference (0 rpm). Figure 2-5 demonstrates that 
the mechanical properties, elastic modulus and maximum strength, change as function of the 
rotation speed of the mandrel. The samples collected at a high rotation speed, such as 500 rpm 
and 2000 rpm, show higher elastic modulus and mechanical strength in the circumferential 
direction.  
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Figure 2-5. Elastic modulus and ultimate strength of silk-fibroin electrospun nets produced 
with a rotating collector. These properties in both longitudinal and circumferential directions 
change with the rotation speed. “ ” shows that the mechanical property of the sample in the 
longitudinal direction is significantly different from that in the circumferential direction 
(p<0.05). 
On the contrary, the samples collected at a low rotation speed, such as 100 rpm, and 
those collected from a static rectangular collector (0 rpm) show higher elastic modulus and 
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mechanical strength in the longitudinal direction. According to the data, an inversion point for 
the anisotropy of mechanical properties is estimated to be around 200 rpm. However, at 
several rotation speeds, no statistically significant differences between the mechanical 
properties in the two directions are found. Results also show that the strengths of fibroin 
nanofiber scaffolds fabricated in various conditions were always low – no higher than 1.7 MPa. 
2.3.1.3 PCL anisotropic mechanical properties 
PCL nanofiber scaffolds were prepared by electrospinning fibers on a rotating cylindrical 
collector with a diameter of 20 mm at varied rotation speeds, including 100, 250, 500, 1000, 
1500 and 2000 rpm. Similar as fibroin, electrospun PCL samples for 0 rpm were prepared by 
using a static rectangular collector with the same projected area as the cylindrical collector. 
Samples for mechanical testing were also collected in both longitudinal and circumferential 
directions. It is found that the mechanical properties of PCL samples show more anisotropic 
behaviors than fibroin samples. The anisotropy is also dependent on the rotation speed of the 
mandrel collector (Figure 2-6). The samples collected at a low rotation speed, such as 0, 100, 
250, 500 and 1000 rpm, show higher elastic modulus and ultimate strength in the longitudinal 
direction. The samples collected at a high rotation speed, such as 1500 and 2000 rpm, show 
higher elastic modulus and ultimate strength in the circumferential direction. The estimated 
inversion point for the anisotropy is between 1000 and 1500 rpm.  
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Figure 2-6. Elastic modulus and ultimate strength of PCL electrospun nets produced with a 
rotating collector. These properties in both longitudinal and circumferential directions 
change with the rotation speed. “ ” and “ ” show that the mechanical property of the 
sample in the longitudinal direction is significantly different from that in the circumferential 
direction (p<0.05 and p<0.01, respectively). 
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2.3.1.4 Mechanical properties of small diameter constructs  
PCL tubular constructs with a small diameter were prepared by electrospinning fibers on 
a cylindrical collector with a diameter of 4.96 mm rotating at 100 rpm (Figure 2-7). Specimens 
(15x3 mm) cut along the longitudinal and circumferential directions confirm the anisotropic 
mechanical behavior of the electrospun materials. In longitudinal direction, an elastic modulus 
of 11.82 ± 0.55 MPa and an ultimate strength of 7.25 ± 0.71 MPa were obtained; in the 
circumferential direction, the elastic modulus and ultimate strength were 4.04 ± 1.17 MPa and 
3.55 ± 0.54 MPa, respectively. Thus, the mechanical anisotropic index (longitudinal-to-
circumferential ratio of elastic modulus) results equal to 2.92. 
 
 
Figure 2-7. PCL tubular construct prepared by electrospinning.  
2.3.1.5 Effect of collector shape   
In order to test the assumption that the anisotropic mechanical properties are related to 
the geometrical shape of the collector, we have designed a series of collectors which are 
characterized by different width-to-length aspect ratios (Figure 2-8). It was found that nets 
electrospun on a slender rectangular collector with higher width-to-length ratio present higher 
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modulus and strength along the length compared to those electrospun on a collector with 
lower width-to-length ratio. For example, for a width-to-length aspect ratio of 6, a mechanical 
anisotropic index of 2.27 was found. 
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Figure 2-8. Effect of collector shape on the mechanical property of PCL electrospun material. 
Elastic modulus along the two principal directions of the electrospun nets is reported as function 
of the length/width ratio of the collector. 
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2.3.2  Multilayered PCL-fibroin scaffold produced by a double electrospinning 
process 
2.3.2.1 Chemical and thermal characterizations of the structure 
PCL and silk-fibroin have been electrospun on a cylindrical collector rotating at a 
constant velocity to form a composite scaffold. With the new double-electrospinning apparatus 
described above, a multi-layered electrospun structure is formed and consists of an ultrathin 
layer of fibroin nanofibers, an interlayer of mixed nanofibers of fibroin and PCL, and a thick 
layer of PCL nanofibers. FT-IR analyses of the two opposite surfaces confirm that the layers are 
completely different in the composition (Figure 2-9). The ATR FT-IR spectra show the presence 
of pure PCL on one side (called PCL side) and fibroin on the other side (called fibroin side). 
Additionally, the shoulder at 1730 cm
-1
 in the FT-IR spectrum of the fibroin side revealed a 
limited presence of PCL.  
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Figure 2-9. ATR FT-IR analysis of the scaffold shows completely different compositions on the 
two surfaces. PCL side shows the characteristic spectrum of PCL, and fibroin side shows the 
characteristic spectrum of prevalent β-sheet fibroin and a small contamination of PCL due to the 
limited thickness of the fibroin layer. 
Figure 2-10 compares the DSC curve of a PCL-fibroin multilayered material with that of a 
pure electrospun PCL material. In the DSC analysis, the presence of fibroin is revealed by a small 
endothermic peak around 280 °C, which is corresponding to thermal degradation of silk-fibroin. 
It is known from previous results that the degradation peak area for a pure electrospun fibroin 
material is in the range of 230-250 J/g. Thus, using the area of the small peak shown in the 
composite scaffold (around 10-12 J/g), the overall content of fibroin inside the multilayered 
scaffold can be estimated to be around 5% in weight. The degrees of crystallinity of PCL for PCL 
and PCL/fibroin samples are equal to 40.4 % and 37.5 %, respectively. 
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Figure 2-10. DSC thermographs for PCL/fibroin multilayered material, pure PCL and pure 
Fibroin. The small endothermic peak at 280 °C, which is common to fibroin and PCL/fibroin 
multilayered material, is attributed to the thermal degradation of silk fibroin.  
2.3.2.2 Anisotropic mechanical properties of the multilayered structure 
The mechanical properties of nanofibrous multilayered PCL-fibroin scaffolds have been 
studied and evaluated in comparison to the mechanical properties of pure PCL scaffolds 
prepared in the same conditions (Figure 2-11a). No significant differences in elastic modulus or 
in ultimate strength (data not shown) are found between multilayered PCL-fibroin scaffolds and 
pure PCL scaffolds in both circumferential and longitudinal directions. This is found on the 
samples collected at a low rotation speed (150 rpm) and on those collected at a high rotation 
speed (1500 rpm).  
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Figure 2-11. a) Elastic modulus of multilayered PCL-fibroin materials and pure PCL materials. 
The material fabrication used a cylindrical collector rotating at a low speed (150 rpm) and a 
high speed (1500 rpm). All the tests were performed on the circumferential direction “C” and 
the longitudinal direction “L” of the samples. No significant differences in elastic modulus were 
found (p>0.05). b) Representative stress-strain curves of hydrated fibroin, dry fibroin, PCL, and 
PCL-fibroin electrospun nets. The material fabrication used a cylindrical collector rotating at a 
high speed (1500 rpm). All the tests were performed on the circumferential direction of the 
tubular scaffolds.  
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Therefore, fibroin does not significantly contribute to the mechanical property of the 
multilayered composite scaffold. This is also shown by representative stress-strain curves for 
multilayered PCL-fibroin material and pure PCL electrospun material using specimens cut in the 
circumferential direction (Figure 2-11b). These curves also show that the mechanical property 
of fibroin electrospun material is dependent on the humidity; it is much stiffer and stronger in a 
dry condition than it is in a hydrated condition. 
2.3.2.3 Endothelial cell characterization 
Endothelial cell culture test was performed on flat electrospun constructs using primary 
arterial endothelial cells (Figure 2-12).  
 
 
Figure 2-12. SEM images of bovine pulmonary artery endothelial cells seeded on the fibroin side 
of the multilayered structure (4 days in culture). 
A low concentrated cell suspension was seeded on the two different surfaces of the 
multilayered electrospun structure. Cell morphology and adhesion site were examined after 4 
days of culture. Endothelial cells seeded on the fibroin side resulted in a highly spread 
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morphology, protruding cytoplasmic interconnections between the cells along a larger number 
of electrospun fibers. 
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2.4 Discussions 
The present study has reported the development of electrospinning processes of silk-
fibroin, PCL and PCL-fibroin multilayer scaffolds for engineered vascular construct. Using a 
single-spinneret electrospinning system with a flat collector, we have optimized electrospinning 
parameters to obtain defect-free, uniform nanofibers from pure PCL and pure silk-fibroin, 
respectively. In particular, the effects of applied voltage, protein concentration, feed rate and 
environmental humidity on the fibroin fiber diameter are demonstrated. Using a rotating 
cylindrical collector, anisotropic mechanical behaviors of these pure nanofiber materials are 
obtained and the anisotropy is found to be dependent on the rotation speed of the collector. In 
addition, we have developed a new double-electrospinning system, and have achieved a 
promising combination of mechanical property and biological property with a biohybrid 
nanofibrous scaffold made from PCL and silk-fibroin.    
2.4.1  Electrospinning of silk fibroin 
A major difference in fibroin electrospinning and characterization presented here from 
previous studies [131,132] is that we have taken the environmental relative humidity (RH) and 
the hydration state of a fibroin sample into consideration. We have shown that the diameter of 
fibers electrospun at 45% RH were about half of that at 70% RH (Figure 2-3d). It is likely because 
water molecules reduce the electric charge density on the developing fibers, thus reducing the 
driving force for fiber elongation and diameter reduction. Also, a single fiber can be stretched 
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more in a dry environment because the viscosity remains low for a longer time, an effect 
equivalent to extending the distance from the needle, while a fiber in a more humid 
environment becomes solid faster and experiences a lower degree of stretching. In addition, we 
have demonstrated the difference in mechanical properties between dry and hydrated fibroin 
nets (Figure 2-11b). It is found that hydration highly reduces stiffness and strength of the 
electrospun material. Because the scaffold is often used in the hydrated state, the majority of 
mechanical characterizations performed here are based on hydrated samples. The ultimate 
tensile strengths reported in this study are comparable to the values reported by Soffer et al. 
[133] who electrospun hydrated fibroin nets from a PEO/fibroin water solution, but the elastic 
modulus reported here are much higher, ranging from 5.32 to 12.11 MPa. The difference is 
likely attributed to a much higher testing rate (3 mm/min compared to 0.2 mm/min) and the 
preconditioning cycles used in the present study. 
2.4.2  Effect of the rotation speed and the collector shape on anisotropic mechanical 
properties 
The present study have shown that varying rotation speed leads to changes in the 
material mechanical anisotropy index which is defined as the ratio of the mechanical property 
in the longitudinal direction to that in the circumferential direction. With the rotation speed 
varying from 0 to 2000 rpm, anisotropy indices of elastic modulus range from 1.7 to 0.35 for 
PCL material, and anisotropy indices range from 1.2 to 0.70 for fibroin material. PCL shows 
more gradual changes in the anisotropy index with the rotation speed, and a wider range of 
anisotropy indices is achievable with PCL. In addition, no significant differences are found 
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between pure PCL nets and multilayered PCL-fibroin nets both at 150 rpm and at 500 rpm. This 
suggests that mechanical properties of a PCL-fibroin bi-layered system  are similar to those of a 
pure PCL electrospun material. This could be due to the small amount of fibroin (~5% in weight) 
in the composite construct according to the DSC analysis results. The dependence of the 
mechanical anisotropy index on the rotational speed could be explained by the relationship 
between fiber alignment and rotational speed, according to previous studies which showed 
that a rotational collector tended to align the fibers along the circumferential direction at 
higher rotation speeds [134]. The nanofiber alignment in the circumferential direction happens 
when the tangential velocity at the collector surface exceeds the velocity at which the 
nanofibers approach the collector, particularly when the rotation speed becomes higher. 
Additionally, many studies have shown a strong correlation between mechanical properties and 
fiber alignment in non-woven electrospun materials [135–137]; progressive alignment of the 
fibers in one direction improves elastic modulus and tensile strength of the material in the 
same direction.  
It is also noticed in this study that at 0 rpm and at lower rotation speeds, both PCL and 
fibroin materials show higher modulus and strength in the longitudinal direction than in the 
circumferential direction. Because there is no mandrel rotation, it may involve the effect of 
collector shape. In order to test the assumption that the anisotropic mechanical properties are 
related to the geometrical shape of the collector, we have designed a series of collectors which 
are characterized by different width-to-length aspect ratios (Figure 2-8). It was found that nets 
electrospun on a slender rectangular collector with higher width-to-length ratio present higher 
modulus and strength along the length compared to those electrospun on a collector with 
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lower width-to-length ratio. The distortion of the electric field in the air gap might induce the 
alignment of fibers along the prevalent geometrical direction and thus higher mechanical 
properties along that direction (See Figure 2-13). The collector shape effect on the mechanical 
anisotropic index is also important at lower rotation speeds when the effect of mandrel 
rotation is negligible. The inversion point, where the anisotropic index is equivalent to 1, 
suggests the balance between the collector shape effect and the rotation speed effect. It is 
about 1200rpm for PCL and 150rpm for fibroin.  
 
 
Figure 2-13. Effect of the shape of the collector. A distortion of the electric field in the air gap 
might induce a preferential alignment of nanofibers along the prevalent geometrical 
dimension of the collector 
At low rotation speed of the mandrel the material in the longitudinal direction is 
stronger and stiffer than in circumferential direction. This property is desired for vascular grafts. 
Therefore, we also produced constructs with a smaller diameter (4.76 mm) at a low rotation 
speed of 100 RPM. After mechanically testing the construct in longitudinal and in 
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circumferential directions we found that the anisotropic behaviour was also demonstrated by 
small diameter constructs. In particular, elastic modulus and ultimate strength in the 
longitudinal direction are higher than the respective values in the circumferential direction. The 
longitudinal-to-circumferential ratio was 2.92. 
2.4.3 Double electrospinning system 
Double electrospinning combines the advantageous properties of two types of 
materials, but more importantly, it better integrates their nanofibers compared to a simple 
overlapping of nanofibers. We have shown that the multilayered structure resulted from 
double electrospinning improves biological properties of PCL as endothelial adhesion potential 
on the scaffold surface increases with a natural cell-conducive polymer (fibroin), while it retains 
superior mechanical properties of the synthetic slow degradable polymer (PCL). Furthermore, 
as shown in Figure 9b, the stress-strain behaviors of fibroin and PCL are quite different, which 
result in completely different behaviors during deformation. As no strong adhesion exists at the 
PCL and fibroin interface, a simple overlapping of a PCL layer and a fibroin layer leads to 
delamination of the construct during deformation. Therefore, the fundamental importance of 
the double electrospinning system resides in the possibility to produce a mixed fiber interlayer. 
The intermixed region acts like an active interphase that transmits interfacial forces and avoids 
delamination. Different from the other recently developed double electrospinning system by 
Baker et al. [137], the system established in the present study designs two charge needles, from 
which the polymers solutions are ejected, to move concurrently along the rotating mandrel, 
thus resulting in a more effective mixing of the different materials. In addition, there are no 
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charged shields placed perpendicularly to the mandrel, thus preventing any modifications of 
the electric field in the region between the charge spinnerets and the collector.  
2.4.4  Application of the scaffolds in tissue engineering 
Mechanical property and surface biological property are both important for vascular 
scaffolding materials. To reproduce anisotropic mechanical property of arteries, engineered 
vascular scaffolds need sufficient radial compliance and relatively higher longitudinal stiffness 
(anisotropy index > 1). Thus electrospinning processes at lower rotation speeds of the mandrel 
are likely useful to produce these anisotropic scaffolds, and changing the mandrel rotation 
speed makes the anisotropy tunable, particularly with PCL bulk materials. Using a multilayer 
structure with bulk PCL and limited amount of fibroin on the surface, we can obtain not only an 
optimized combination of anisotropic mechanical property, but also surface properties for cells. 
Compared to PCL, a fibroin-based matrix better supports endothelial cell growth due to the 
favorable biological properties of the silk protein. Besides the composition, the net morphology 
is also important for the formation of effective endothelial layer. Other studies also 
demonstrated that three-dimensional silk-fibroin nets derived from the cocoons of the silk 
worm, Bombyx mori, support the attachment, spread and growth of a variety of human cell 
types of diverse tissue origins [138]; in particular, it has been reported that the regenerated 
silk-fibroin maintains normal cell phenotypes and functions of primary human macro- and 
micro-vascular endothelial cells as well as endothelial cell lines [138], and has anti-
thrombogenic potential [124]. 
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2.5 Conclusions 
We have demonstrated a double-electrospinning technique to produce a robust tubular 
scaffold with well-integrated nanofibrous structure, anisotropic mechanical behaviour and 
endothelial-conducive surface, for vascular tissue engineering. A thick bulk PCL mesh of 
nanofibers, an intermediate intermixed fibrous layer, and a thin layer of silk-fibroin nanofibers 
have been combined to form a multilayered structure which is stable against mechanical 
delamination. The structure can be stiffer in the longitudinal direction and more compliant in 
the circumferential direction, and reach up to 2.5 in the longitudinal-to-circumferential ratio in 
this study. The combination of the collector shape and the collector rotation allows us to 
produce a tubular structure with tunable anisotropic mechanical properties. The phenomenon 
has been extensively demonstrated in the case of electrospinning on a 20 mm mandrel, while 
can be generally applied. In fact, samples obtained with a 4.96 mm mandrel rotating at 100 rpm 
confirm the anisotropic behavior reaching a longitudinal-to-circumferential ratio higher than 
2.9. In addition to vascular scaffolds, the system and technique developed in this study will be 
important for many other tissue engineering applications as well. 
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3 BIOMOLECULE GRADIENT IN MICROPATTERNED 
FIBROUS SCAFFOLD FOR SPATIOTEMPORAL RELEASE 
 
Abstract 
 
Delivery of drugs, growth factors or other biomolecules dramatically increases the 
scaffold ability to direct and sustain cell attachment, migration, proliferation and, ultimately, 
cell activity both in vitro and in vivo applications. Moreover, spatial confinement, temporal 
control and specificity of drug presentation are pivotal factors in directing cell behaviour and 
tissue repair and remodelling. 
Using a modified double-electrospinning system, we have demonstrated heterogeneous 
nanofibrous scaffolds composed of degradable polymers poly(ε-caprolactone) (PCL) and 
poly(lactide-co-glycolide) acid (PLGA) characterized by compositional and biochemical gradients 
along the scaffold thickness. We have revealed the different behaviours of acid terminated 
PLGA (PLGAac) and ester terminated PLGA (PLGAes) during degradation in an isotonic 
phosphate solution.   
By means of fluorescent molecules and fluorescently-labeled albumins encapsulated in 
the nanofibers, we have successfully visualized the concentration profile of the scaffold 
 59 
 
constituents. Spatially-confined delivery was demonstrated for a variety of micropatterned PCL-
PLGAac scaffold with a novel side-by-side release test. These electrospun composite graded 
scaffolds have shown programmable delivery of the model molecules to one specific surface of 
the device with efficiency of separation as high as 95%. In addition, we obtained simultaneous 
and sequential release of two different model proteins on the two surfaces of the newly 
engineered, composite electrospun scaffolds, and we showed that release kinetics can be 
influenced by changing the initial pattern of drug distribution and the composition of the 
scaffold. We believed that scaffold preparation and release micropatterns presented in this 
work may represent the platform for the development of novel multifunctional matrices able to 
control and direct the process of tissue regeneration. 
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3.1 Introduction 
Growing evidence has shown that tissue morphogenesis is coordinated by the spatial 
arrangement and temporal duration of multiple molecules in the three-dimensional (3D) 
extracellular matrix [93,94]. This has stimulated recent advances in the design of a new 
generation of biomaterials, which aim to mimic the spatio-temporal regulatory mechanisms of 
molecules for tissue regeneration or other therapeutic purposes [92,105,108]. To incorporate 
biomolecules into biomaterials and sustain the biomolecule release in vitro or in vivo, methods, 
such as adsorption and covalent binding [83,84], encapsulation [85,86], and addition during 
scaffold formation [87], have been developed. To deliver biomolecules in a more specific or 
spatiotemporally-controlled manner, recent developments in the area have demonstrated the 
advantages of micro- and nano-structured devices [70,100,101] and material scaffolds [102–
104]. For tissue engineering and regenerative medicine, the need of precisely regulating 
regenerative molecule microenvironments is ever increasing. The majority of newly-developed 
molecule-impregnated scaffolds, however, are only capable of achieving sustained or 
temporally-controlled molecule release. Few techniques are available to engineer 3D scaffolds 
that define spatial organization of molecules or spatially-controlled release. The spatial control 
over release is critical to coordinate cell behaviors for tissue pattern formation [92,102]. Also, 
because the functions of many biomolecules such as proteins are cell- and tissue- specific, 
selective release of molecules that target specific cell types or tissue formation without 
influencing the activity of other cell populations or tissue functions is important to establish 
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both in vitro physiological tissue models and in vivo tissue regeneration [105–107]. Currently, 
techniques of 2D on-chip patterning or 3D segregation of molecule delivery materials are 
available to spatially confine biomolecules [108–110]. However, to meet various physiological 
needs of tissue regeneration, a 3D scaffold should not only present a multitude of regenerative 
biomolecules in a sustained manner at defined locations, but also be capable of precisely 
programming spatiotemporal control to meet physiological needs as well as satisfying other 
tissue-specific requirements such as mechanical properties. This is a challenging task, given the 
fact that it is difficult to simultaneously build multiple functional features into one scaffolding 
material.  
Electrospinning of biomaterials has been increasingly used to fabricate tissue 
engineering scaffolds in the last decade, because they offer adequate mechanical property for 
implantation [65], and nanostructure guidance to cell adhesion and proliferation [53,54]. 
Electrospun biomaterials, consisting of nanofibers that mimic the structure of the native 
extracellular matrix, provide a wide range of mechanical and chemical properties via fiber 
composition, diameter, distribution and porosity [45,47,49,70]. Recently, various methods using 
electrospun fibers to encapsulate and deliver molecules have been established [46]. This could 
dramatically increase the scaffold ability to regulate various cell activities. Due to inherently 
high surface area of electrospun materials, these constructs allow high molecule loading and 
efficient release in situ. However, the developed techniques have been limited to tune 
molecule release kinetics. As far as we know, no electrospun constructs with capability of 
spatially-defined or spatiotemporally-controlled delivery of biomolecules have been 
demonstrated before. 
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We have previously developed double-electrospinning technique to fabricate 
interpenetrating networks of nanofibers from different polymers [43]. We also demonstrated 
the use of diverse nanofibers in a tailored proportion to engineer the surfaces or anisotropic 
mechanical properties of tissue scaffolds. By furthering the techniques to program 
micropatterns of molecule-impregnated nanofibers, the present study aims to demonstrate 
composite, electrospun biomaterials that are capable of selectively releasing molecules in 
spatially- and temporally- controlled manner. Herein, heterogeneous nanofibers composed of 
degradable polymers poly(ε-caprolactone) (PCL) and poly(lactide-co-glycolide) acid (PLGA), 
have been used to form scaffolds with compositional and biochemical gradients along the 
scaffold thickness. Using PLGA nanofibers to encapsulate small molecules or proteins, we have 
characterized compositional and morphological changes as well as degradation behaviours of 
these composite scaffolds for up to 50 days in vitro.  
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3.2 Materials and Methods 
3.2.1 Materials 
LACTEL
®
 50:50 poly(d,l lactide-co-glycolide) acid with a carboxylate end group and 
intrinsic viscosity of 0.67 dL/g, hereinafter referred to as PLGAac, was purchased from DURECT 
Corp. (Pelham, AL). PURASORB
®
 50:50 poly(d,l lactide-co-glycolide) acid with an ester end group 
and intrinsic viscosity of 0.32-0.48 dL/g, hereinafter referred to as PLGAes, was obtained from 
Purac Biomaterials (Lincolnshire, IL). PCL with molecule weight of 80 kDa, chloroform (CF), N,N-
dimethylformamide (DMF), methylene chloride (MC), methanol (MetOH),  1,1,3,3,3-hexaflouro-
2-propanol (HFIP),  sodium phosphate (NaH2PO4), sodium phosphate dibasic (Na2HPO4) and 
sodium azide were all purchased from Sigma Aldrich (St. Louis, MO). Polymers were used as 
received. Solvents were of analytical grade and used without any further purification. Isotonic 
phosphate buffer solution was prepared by mixing a 0.13 M solution of NaH2PO4  with 0.002% 
sodium azide and a 0.13 M solution of  Na2HPO4 with 0.002% sodium azide, and then adjusting 
pH and osmolarity to 7.4 and 290-300 mosmol/L, respectively. Sodium azide was used to 
prevent bacterial contamination. 
Fluorescent dyes, rhodamine 123 (Rh123) with green emission, rhodamine-B (RhB) with 
red emission, coumarin with blue emission, as well as fluorescently-labelled proteins, 
fluorescein isothiocyanate conjugate bovine serum albumin (AlbF) with green emission and 
tetra-methyl-rhodamine isothiocyanate conjugate bovine serum albumin (AlbT) with red 
emission were all obtained from Sigma Aldrich. The molecular weight, chemical formula, 
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excitation/emission wavelength and usage in this study of fluorescent dyes and fluorescently-
labelled albumins are summarized in Table 3-1. 
 
Dyes Molar 
Mass 
[g/mol] 
Chemical formula Excitation
/Emission 
[nm] 
Use 
Rhodamine 123 
(Rh123) 
≈760 
 
485/535 Release/ 
Imaging 
Rhodamine-B 
(RhB) 
479.02 
 
560/590 Imaging 
Coumarin 146.14 
 
360/450 Imaging 
Albumin-
Fluorescein 
isothiocyanate 
(Alb F) 
66000/ 
389.4 
7 to 12 moles of FITC per mole 
of albumin 
485/535 Release 
Albumin-Tetra-
methylrhodamine 
isothiocyanate 
(Alb T) 
66000/ 
364.2 
About 1 mole of TRITC per 
mole of albumin 
560/590 Release 
Table 3-1. Fluorescent dyes, fluorescent-labeled albumins properties and their uses 
3.2.2 Preparation of electrospinning solutions 
PCL was dissolved in 75/25 CF/DMF at a concentration of 10% (wt). For both PLGAac and 
PLGAes, the pre-spinning polymer solutions were prepared by dissolving the polymer in the 
mixture of HFIP and DI water with a ratio of 7:1 (vol) with a final concentration of 17% (wt). To 
 65 
 
visualize the compositional gradients across the thickness of electrospun scaffolds and to 
characterize the molecule release profiles, fluorescent dyes or fluorescently-labelled albumins 
were added to pre-spinning solutions. DI water was used to dissolve fluorescent dyes. A 
solution of Rh123 or RhB with a concentration of 1 mg/ml was prepared with DI water, and 
then mixed with HFIP (7:1). Subsequently, the mixture was used to dissolve PLGAac and 
PLGAes. A PCL/coumarin pre-spinning solution was obtained by dissolving the polymer at a 
concentration of 8% (wt) in a ternary solvent mixture of MC:DMF:MetOH with a ratio of 5:3:2 
(vol), where MetOH served as the carrier for coumarin. This was done by first dissolving 10 mg 
of coumarin in 300µl of DI water to obtain the stock solution, and subsequently adding MetOH 
to the stock solution to obtain a 5 mg/ml solution of coumarin, and finally preparing the pre-
spinning solution with the ternary solvent mixture. To prepare PLGAac nanofibers for in vitro 
release of fluorescent-labelled albumins, 5 mg of AlbF or AlbT was dissolved in 90 µl of DI 
water. Then, 630 µl of HFIP was added to the solution, forming a mixture to dissolve 220 mg of 
PLGAac, resulting in a 17% (wt) polymer solution. The overall content of albumin was 2.3% with 
respect to the mass of the dry polymer. During the entire process, the dye-containing solutions 
were always shielded from light to preserve the activity of fluorescent species. 
3.2.3 Double-electrospinning process 
The electrospun composite with the compositional gradient of distinct materials across 
the composite thickness was prepared through programming the sequential and/or 
simultaneous electrospinning processes of PCL and PLGA on a rotating mandrel collector, using 
a modified double-electrospinning system previously described by us [43]. Briefly, a layer of PCL 
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nanofibers, an intermixed layer of PCL and PLGAac (or PLGAes) nanofibers, and a layer of PLGA 
electrospun fibers were deposited in sequence on the grounded cylindrical aluminum collector. 
The design of the compositional patterns along the thickness of the scaffold was achieved by 
controlling 3D movements of a collector, in coordination with spinning processes separately 
programmed. The cylindrical collector, with 8 mm in diameter, rotated at a constant velocity by 
a brushless rotating electric motor (BLF230C-A, Oriental Motor, U.S.A. CORP., Torrance, CA). 
Each solution was individually stored in a 5 ml syringe. The syringe was connected to a blunt-
ended needle that served as a charged spinneret. Each spinneret placed at the opposite side of 
the rotating collector, were perpendicularly oriented with respect to the principal axis of the 
collector, and connected to a separate high voltage power supply (ES30P-10W, Gamma High 
Voltage Research Inc, Ormond Beach, FL). Both spinnerets moved in concert over an 18 cm path 
with a speed of 5m/s along the collector mandrel which was under the control of a linear 
motorized stage (EZS3D025-C, Oriental Motor). The feed rate of each solution varied 
independently via separate syringe pumps (NE-300, New Era Pump Systems, Farmingdale, NY) 
during the course of deposition. The electrospinning flow rates that allowed the formation of 
defect-free nanofibers were determined beforehand for each solution, and used to define the 
maximum flow rates, which were 0.6ml/hr for PLGA fibers and 1.1ml/hr for PCL fibers. The 
collector geometry, the concentration of polymer solutions, and apparent density of pure PCL 
and PLGA electrospun nets were used to establish a correlation between the feed rate and the 
deposition rate of each polymer per unit of surface area. Detailed information of the solution 
compositions and electrospinning parameters is listed in Table 3-2.  
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Polymer Loaded 
dye 
Solvent  
mixture 
Polymer 
conc. 
[% wt] 
Dye 
content 
[%] 
wtdye/wtpol. 
Voltage 
 
[kV] 
Work 
Distance 
[cm] 
Feed 
rate 
[ml/h] 
PLGAac 
PLGAes / 
HFIP/water 
7/1 vol. 17 / 26 20 0.15-0.6 
PLGAac 
PLGAes 
Rh123 
RhB 
HFIP/water 
7/1 vol. 17 ≈ 0.012 24 20 0.15-0.6 
PLGAac AlbF AlbT 
HFIP/water 
7/1 vol. 17 2.23 22 20 0.15-0.6 
 
       
PCL / CF/DMF 3/1 vol. 10 / 26 24 0.3-1.1 
PCL Coumarin MC/DMF/MetOH 5/3/2 vol. 8 ≈ 0.05 20 20 0.3-1.1 
Table 3-2. Characteristics of polymer/dye solutions and electrospinning parameters 
The electrospinning process was performed at room temperature in open atmosphere 
with a relative humidity of 20-25%. The overall thickness of the electrospun nets was measured 
using a micrometer screw gauge. The design thickness of PCL-PLGA materials was 150 µm; 
samples with actual thickness outside of the range 135-165 µm were discarded. When 
fluorescent molecules were used, the entire apparatus was shielded from light to preserve the 
dyes. Electrospun samples were stored in a dessicator and kept in the dark.  
3.2.4 Characterization of nanofiber morphology 
The morphology of the electrospun fibers was observed using a JSM-6480LV scanning 
electron microscope (SEM) (JEOL Ltd., Tokyo, Japan) at 5.0 kV. Samples were sputter-coated 
with gold prior to analysis. 
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3.2.5 Characterization of compositional micropattern 
Scaffolds loaded with fluorescent dyes were embedded in cryo-optimum-cutting-
temperature compound (Andwin Scientific, Schaumburg, Germany) or in paraffin for histology. 
A series of 15 µm-thick sections were obtained with a cryostat or rotary microtome for confocal 
imaging. The cross-sections of the nanofiber scaffolds loaded with fluorescent species were 
examined under a Zeiss LASER Scanning 510 confocal microscope equipped with AR, HE/Ne and 
diode laser sources (Carl Zeiss Inc, Jena, Germany). The images were used to assess the dye 
distribution in the nanofibers and along the thickness of the nets. Compositional profiles of 
scaffolds were determined by measuring the color intensity of dyes in the confocal images, 
using ImageJ software (http://rsbweb.nih.gov/ij/). Fluorescent profiles were obtained by 
averaging at least 6 profiles acquired from 3 different samples. 
3.2.6 Thermal analysis 
The thermal analyses were performed using a differential scanning calorimeter (DSC) 
(DSC 204 F1 Phoenix®, Aurora, IL, USA) under flushing nitrogen (100 ml/min). Each sample was 
first heated from -110°C to 120°C with an incremental rate of 10 °C/min and held at each 
temperature for 3 min. The sample was then slowly cooled to −110°C with liquid nitrogen at a 
cooling rate of 5 °C/min and reheated for a second scan to 120°C at a rate of 10°C/min. For the 
PCL-PLGA composites, the glass transition of PLGAac and PLGAes were measured from the first 
heating scans. The transformation was clearly visible and was accompanied by an appreciable 
enthalpic relaxation effect due to the aging of the polymer. Therefore, the onset point and 
inflection point were both reported. In the second heating scan, the glass transitions of PLGA 
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were not visible, due to the melting peak of PCL. The peak temperature of the melting 
transition of PCL was recorded and melting peaks of PCL in pure PCL sample and PCL-PLGA 
samples were quantitatively determined by integration. The crystallinity degree of PCL (αPCL) 
was determined by comparing the melting enthalpy of PCL (ΔHPCL) for PCL nanofibers with the 
theoretical value of a sample with 100% crystalline PCL (ΔH100%), which equals to 139.4 J/g 
[139]. Thus, αPCL = 100*(ΔHPCL / ΔH100%). The melting enthalpy was determined by calculating 
the area of the endothermic melting peak of PCL. Under the assumption that melting enthalpy 
of PCL remained constant in PCL-PLGA samples, αPCL was used to determine the fraction of PCL 
nanofibers. 
3.2.7 Hydrolytic degradation analysis  
Hydrolytic degradation analyses were performed on electrospun scaffolds at 37 °C in 
phosphate buffer solution (pH = 7.4) under constant mild agitation up to a maximum of 6 
weeks. For each electrospun net, specimens were immersed in 5 ml of phosphate buffer 
solution in separate test tubes. Triplicate samples for each experimental condition were 
withdrawn at a predetermined time, carefully washed in DI water and dried under vacuum in a 
dessicator for 48 hours. Then, the samples were weighed on an analytical balance. Using the 
gravimetric method, weight loss of each sample was then determined and averaged. 
Corresponding changes of nanofiber morphology were monitored using SEM micrographs. 
Molecular weights of PCL, PLGAac and PLGAes were determined by gel permeation 
chromatography (GPC) (GPCmaxTM, Viscotek, Houston, TX, USA) with a differential refractive 
index (RI) detector (Viscotek 3580), and a set of Viscotek viscogel columns with THF as the 
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eluent at 30 °C. The analytical GPC was calibrated using monodisperse polystyrene standards. 
Molecular weights of the as-spun scaffolds and those after each degradation time were 
measured. The GPC curves of the materials presented a bi-modal distribution. The overlapped 
peaks were thus deconvoluted into two separate asymmetric peaks with the least-squares 
method and assigned to PCL and PLGAac (or PLGAes). The peak-fitting parameters were 
conditioned using the peak parameters of the parent materials. The molecular weights 
corresponding to individual deconvoluted peaks were also determined.  
3.2.8 Release profile characterizations 
For molecule release characterizations, the circular samples with 24 mm in diameter 
were cut from PCL-PLGAac and PCL-PLGAes scaffolds loaded with fluorescent dye or 
fluorescently-labelled albumin. For each experimental condition, 3 samples were used for 
analyses. Samples were placed in a custom-made diffusion chamber in which each surface of 
the electrospun scaffold faced a different reservoir chamber filled with 1ml of buffer solution. 
The two reservoirs used SecureSeal hybridization chambers (Grace Biolabs, Bend, OR) to seal 
the surface. Each reservoir had small holes for sampling and changing solutions. The holes were 
covered with silicone sealing tap during experiments to prevent evaporation. Thus, the 
molecule movements between the reservoirs could only be through the pores of the 
electrospun materials. The release tests were performed at 37 °C. Samples of buffer solutions in 
both reservoirs were collected every day during the first 16 days, and subsequently once a 
week. After samples were taken, the reservoir chambers were rapidly rinsed with DI water and 
refilled with fresh phosphate buffer at 37°C. Samples of 200 µl in triplicates were analyzed in 
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96-well microplates with a Victor 2 microplate reader (PerkinElmer, Santa Clara, CA) to quantify 
the amount of Rh123, AlbF and AlbT released daily. The concentration and net amount of 
released Rh123, AlbF and AlbT were determined using the respective calibration curves (Table 
3-3). The geometry and porosity of the molecule-releasing scaffolds kept constant for all the 
experimental samples. As various fluorophores were simultaneously released by some samples, 
the possibility of the overlap of the fluorophore emission spectra was examined; no evidences 
of any undesired overlap were found. An efficiency of separation (S) was introduced to quantify 
the capability of confining molecule release to one specific side of the scaffolds. The efficiency 
of separation of a particular molecule between Side A and Side B (Smolecule_A-B) was defined as 
the percentage of molecules released on Side A over the total amount of molecules released on 
Sides A and B for the whole duration of the test. 
 
Rh123   x < 45000                  y = 4.248*10^7 x + 1014                          R2 = 0.987 
Alb F     x < 20000                  y = 639.9 x + 366.9                                  R2 = 0.998 
Alb F   20001 < x < 60000      y = -2.432 x2 + 687.7 x + 327.4               R2 = 0.999 
Alb T    x < 20000                   y = 457.4 x + 389.3                                  R2 = 0.996 
Table 3-3. Calibration curves for Rh123, AlbF and AlbT with the respective coefficient of 
determination. “x” is to the measured fluorescence intensity and “y” is the concentration of the 
molecule in solution expressed in µg/ml. The net mass released can be calculated taking into 
account the known capacity of the release chamber. 
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3.3  Results 
3.3.1 PCL/PLGA scaffolds with micropatterned nanofibers demonstrated custom-
designed compositional gradients 
Using the double-electrospinning apparatus with capability of precisely programming 
the 3D position of different nanofibers, we have formed electrospun multi-component 
structures showing designed micropatterns. Figure 3-1 illustrates a structure which consists of a 
25 µm-thick PCL nanofiber layer, a 100 µm interlayer with mixed nanofibers of PCL and PLGA, 
and a 25 µm PLGA nanofiber layer. The design shows a pattern of pure PCL and PLGA on the 
opposite sides of the surfaces, and an intermediate region in which the PLGA content varies 
gradually between 0 and 100% along with a reversed change of PCL content. This compositional 
gradient across the material thickness was achieved by progressively decreasing the feed rate 
of PCL to 0 while simultaneously increasing the feed rate of PLGA to the maximum value. The 
pattern was designed to produce scaffolds with equal amount of PCL and PLGA in weight. 
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Figure 3-1. Schematic illustration of the cross-section of a PCL-PLGA electrospun scaffold with 
internal compositional gradient. The fraction of PCL nanofibers (shown in blue) decreases 
along the thickness of the material from 1 on the left side (PCL side) to 0 on the right side 
(PLGA side), while the PLGA fraction (shown in red) increases along the thickness of the 
scaffold from 0 to 1. 
To assess the actual composition of scaffolds, DSC analysis was used. Results 
demonstrated that the material composition closely matched the design. The comparison 
between the endothermic melting enthalpies of PCL in the scaffolds and the melting enthalpies 
of pure electrospun PCL, was used to determine the actual amount of PCL and the PCL/PLGA 
ratio in the scaffolds (Table 3-4). PCL nanofibers showed crystallization enthalpy of 55.9 J/g 
during cooling and melting enthalpy of -58.5 J/g in the second scan. As the melting enthalpy of 
100% crystalline PCL is 139.5 J/g, the resulting crystallinity of electrospun PCL nanofibers was 
42%. Also, results from the crystallization and melting enthalpies of PCL-PLGAes and PCL-
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PLGAac scaffolds revealed that the actual PCL content was around 55% in both cases. 
Therefore, the actual PLGA contents were around 45%. Also, the glass transition temperatures 
of PLGAac and PLGAes, determined from the inflection point in the first DSC scan curves of PCL-
PLGA scaffolds, were 39.7 and 38.5 °C, respectively. We also noticed that the glass-rubber 
transition for PLGAes (onset point) started at 35.2 °C, below the working temperature of 37°C. 
The transition zone for PLGAac started at 37.8 °C, just above the working temperature. 
 
Sample 
PCL 
Tm 
 
(II scan) 
[°C] 
∆HPCL 
melting 
(II scan) 
[J/g] 
PCL 
content 
 
[%wt] 
Tc 
 
(cooling) 
[°C] 
∆HPCL 
crystal. 
(cooling) 
[J/g] 
PCL 
content 
 
[%wt] 
PCL 
nanofibers 60.0 -58.5 100.0 27.1 55.9 100.0 
PCL-PLGAes 61.3 -31.9 54.5 27.9 29.7 53.1 
PCL-PLGAac 59.1 -32.2 55.0 26.7 30.5 54.6 
 
Sample 
PLGA 
PLGA content 
(from melting) 
[%wt] 
PLGA content 
(from crystal.) 
[%wt] 
Tg 
(I scan, Onset) 
[°C]  
Tg 
(I scan, Inflection) 
[°C]  
PCL-PLGAes 45.4 46.9 35.2 38.5 
PCL-PLGAac 45.0 45.4 37.8 39.7 
Table 3-4. Thermal properties of PCL and PLC-PLGA electrospun materials. 
Confocal images of the cross-sections of molecule-impregnated nanofiber materials 
further demonstrated that the compositional gradients of composites matched the designed 
nanofiber micropatterns (Figure 3-2). Herein, PCL nanofibers were loaded with a blue 
fluorophore coumarin, while PLGAac nanofibers were loaded with red fluorophore RhB and/or 
green fluorophore Rh123. Figure 2 demonstrated the molecule pattern in a two-component 
scaffold and a three-component scaffold. Figure 3-2a showed the confocal image of a PCL-
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PLGAac material, in which PCL and PLGAac were loaded with blue and red fluorophores, 
respectively. The gradual increase in the red color intensity from the left to the right side of the 
image demonstrates the increase of PLGAac content across the material thickness, whereas the 
attenuation of blue intensity shows the reduction of the PCL fraction in the same region. Also, 
no red signals were found close to the surface on the PCL side, and no blue signals close to the 
surface on the PLGAac side. This reflects the pure polymer design in these regions. However, 
due to the saturation of fluorescent signals, the fluorescent profiles in the high intensity range 
could not be accurately assessed. Figure 3-2b illustrated the design of a three-component 
scaffold, where PLGAac nanofibers were used to impregnate two molecules in the respective 
regions: green Rh123 in the inner region and red RhB in the outer region of the scaffold. Similar 
to the pattern observed in the two-component scaffold, the fluorescent intensity profiles in the 
confocal image reproduced the designed micropattern across the scaffold thickness with 
accuracy except in the high intensity range.  
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Figure 3-2. Design illustrations and confocal images of the gradient micropatterns over the 
thickness of PCL-PLGAac scaffolds. In the design illustrations (a, d) and confocal images (b, e), 
blue color shows PCL nanofibers loaded with fluorophore coumarin, red shows PLGAac 
nanofibers loaded with RhB, and green shows PLGAac nanofibers loaded with Rh123. The 
color intensity profiles (c, f), quantitatively determined from the confocal images, 
demonstrate the changes in the signal intensity of each fluorophore molecule across the 
sample thickness. Results demonstrate good agreement between the design patterns and the 
actual concentration profiles of the molecules or fibers.  
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3.3.2 Hydrolytic analyses of PCL-PLGA scaffolds demonstrated the different 
degradation behaviors and morphological changes of PLGAac and PLGAes 
To compare the hydrolytic degradation behaviors of PCL-PLGAac and PCL-PLGAes 
scaffolds, samples were analyzed with the gravimetric method for weight loss, GPC for changes 
in the polymer molar weight distribution, and SEM for the nanofiber morphology. The results 
demonstrated significant differences between PLGAac and PLGAes during the 6-week hydrolytic 
degradation process. SEM micrographs in Figure 3-3 and Figure 3-4 demonstrate the evolution 
of PCL-PLGAac and PCL-PLGAes scaffolds during degradation. Figure 3-3a and Figure 3-3b shows 
that the morphology and network of PLGAac nanofibers remained virtually unchanged after 1 
week of buffer exposure. During this time period, the average fiber diameter increased about 
25%, from 0.62 ± 0.27 µm to 0.78 ± 0.28 µm. After 3 weeks, PLGAac nanofibers exhibited more 
significant increase in diameter with an average diameter of up to few microns, and the fiber 
network was characterized by soldering-like attachments at the junctions (Figure 3-3c). From 
the SEM images, it was noticed that by week 3, the fibers on the sample surface had partially 
lost their cylindrical and smooth morphology. Also, the PCL nanofibers started to emerge in the 
SEM images; they were underneath the PLGA fibers, exhibiting unaffected cylindrical and 
smooth morphology. Overall, the deformed and swollen PLGAac nanofibers seemed to be 
collapsed onto, and wrapped around, the more stable PCL fibers after 3 weeks of degradation. 
After 5 weeks, the fibrous structure of PLGAac almost disappeared, and a film of PLGAac 
covered the web of PCL nanofibers which were unscathed after degradation (Figure 3-3). From 
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a macroscopic view, it was found that the PCL-PLGAac scaffolds remained dimensionally stable 
and flat for the entire experimental period.  
 
PCL
PLGAac
10um
a – PLGAac nanofibers as spun b – week 1
d – week 5c – week 3  
Figure 3-3. Representative SEM micrographs of the PCL-PLGAac nanofibrous scaffold with an 
internal compositional gradient. Images were taken from the PLGA side. (a) Morphology of 
PLGAac nanofibers as spun. (b-d) Changes in the nanofiber morphology after 1 week (b), 3 
weeks (c), 5 weeks (d) of degradation in phosphate buffer solution at 37°C. The unchanged 
PCL nanofibers underneath the PLGAac layer were found after 5 weeks of degradation (d). 
Scale bar shows 10µm. Scale bar shows 10 µm. 
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Compared to PLGAac, the morphology of PLGAes nanofibers altered much faster (Figure 
3-4). After only 1-day exposure to buffer, the electrospun PLGAes nanofiber network started to 
collapse with extensive soldering-like attachments at the junctions (Figure 3-4b). 
 
10um
10um
10um
f - week 4e - week 2 g - week 6
c – day 3b – day 1 d – week 1
a – PLGAes nanofibers as spun
 
Figure 3-4. Representative SEM micrographs of the PCL-PLGAes nanofibrous scaffold with an 
internal compositional gradient. Images were taken from the PLGA side. (a). Morphology of 
PLGAes nanofibers as spun. (b-f) Changes in the PLGAes nanofiber morphology after 1 day (b), 
3 days (c), 1 week (d), 2 weeks (e), 4 weeks (f) and 6 weeks (g) of degradation in phosphate 
buffer solution at 37°C. The unchanged PCL nanofibers underneath the PLGAes layer were 
found in all these images (b-d). Scale bar shows 10µm. 
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Within one day, the average fiber diameter increased nearly 80%, from 0.50 ± 0.17 µm 
to 0.88 ± 0.10 µm. After 3 days, no fiber-like morphology remained in the PLGAes layer. The 
layer turned into a membrane with an array of small circular pores (Figure 3-4c) whose 
diameter continued to decrease in the first week (Figure 3-4d). At the end of the second week, 
the PLGAes layer was entirely re-structured and became a solid substrate without pores lying 
on the bed of PCL nanofibers. 
Figure 3-4e demonstrated the structure of PCL fibers lying under a fractured portion of 
the PLGAes layer. From then on, the surface of PLGAes layer appeared to be continuously 
eroded by the buffer, and after 6 weeks, a significant amount of material still remained on the 
surface (Figure 4f-g). From a macroscopic view, it was found that the PCL-PLGAes scaffolds 
shrunk and bent toward the PLGAes side, which might be due to the loss of PLGAes pores 
reducing the volume of the PLGAes material. Similar to PCL-PLGAac, in the PCL-PLGAes 
composites, the morphology and network structure of the nanofibers on the PCL side remained 
unchanged during the degradation process. 
To gain further understanding of the hydrolytic degradation processes of the composite 
scaffolds, we characterized changes in overall weight and molecular weight of different PCL-
PLGA scaffolds. Using GPC curves of the component polymers (Figure 3-5), we first determined 
the weight-average molecular weight (Mw), number-average molecular weight (Mn) and 
polydispersity (pdi) of pure PCL, PLGAac and PLGAes materials.  
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3 3.5 4 4.5 5 5.5 6 6.5
Log [MW]
PCL
PLGA ac
PLGA es
 
Polymer Mw 
[kDa] 
Mn 
[kDa] 
pdi 
PCL 137 78 1.8 
PLGAac 43 26 1.6 
PLGAes 36 22 1.7 
 
Figure 3-5. GPC curves and molecule weight analyses of pure PCL, PLGAac, PLGAes materials.  
The weight-average molecular weight (MW), number-average molecular weight (Mn) and 
polydispersity (pdi) are reported. 
Figure 3-6 demonstrated the differences between PCL-PLGAac and PCL-PLGAes scaffolds 
in GPC curves, molecular weight changes and weight loss during hydrolytic degradation. The 
GPC curves exhibited a bimodal distribution. The peak at higher molecular weight was assigned 
to PCL, whereas the peaks at lower molecular weights were assigned to PLGA. GPC results from 
both PCL-PLGAac and PCL-PLGAes materials (Figure 3-6a-b) showed that the PLGA peak 
gradually decreased and shifted towards lower molecular weights, while the PCL peak remained 
unaffected during the hydrolytic degradation. Using deconvolution analysis of GPC curves, the 
contributions of PCL and PLGA, the PLGA content in the scaffold and the number average 
molecular weight of the polymer were determined. As shown in Figure 3-6c, the molecular 
weight of PLGAac slightly decreased between week 2 and week 3 before getting steady at 
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21kDa. The PLGAac content in the scaffold steadily dropped to approximately 22% of the 
original amount after 6 weeks. Compared to PCL-PLGAac, the molecular weight of PLGA in PCL-
PLGAes scaffolds dropped more progressively from 22 to 9 kDa during the experimental period 
(Figure 3-6d). The PLGAes content decreased accordingly. However, when compared to PCL-
PLGAac, there was a higher amount of PLGA content present in PCL-PLGAes scaffolds after 6 
weeks, approximately 40% of the original amount of polymers. Therefore, compared to PLGAac, 
PLGAes degraded more slowly, but underwent chemical breakdown during degradation, 
showing immediate reduction in molecule weight and more rapid loss of nanofiber 
morphology. The weight loss curves for the PCL-PLGAac and PCL-PLGAes scaffolds were 
presented in Figure 3-6e and Figure 3-6f, respectively. The remaining mass of the scaffolds was 
determined by the gravimetric method and by measuring the overall area under the GPC curve; 
both results in similar curves of weight loss.  
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Figure 3-6. GPC analyses of PCL-PLGAac and PCL-PLGAes scaffolds as spun and after the 
hydrolytic degradation tests. (a - b) GPC curves of PCL-PLGAac and PCL_PLGAes; (c - d) 
Changes in number average molecular weight and remaining PLGA content determined by 
the deconvolution of the GPC curves; (e -f) Overall remaining mass percentage of the scaffolds 
determined by the gravimetric method and measurement of the total area under the GPC 
curves. 
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3.3.3 Spatially-controlled release of small molecules from PCL-PLGAac and PCL-
PLGAes scaffolds 
To assess the capacity of PCL-PLGAac and PCL-PLGAes materials for spatially controlled 
release of active molecules, we first performed release experiments using Rh123. PCL and 
PLGA/Rh123 solutions were electrospun to prepare scaffolds following the pattern described in 
Figure 3-1. Release studies were carried out in custom-made diffusion chambers illustrated in 
Figure 3-7a. The two sealed reservoirs filled with phosphate buffer solution were placed on the 
opposite sides of the electrospun scaffolds. The PCL side of the scaffold was set to face the 
buffer reservoir chamber on the “A” side; the Rh123-impregnated PLGA side was placed in 
contact with the buffer reservoir on the “B” side. Daily measurement results of the Rh123 dye 
concentrations in both reservoirs for the first 9 days are shown in Figure 3-7. Figure 3-7b 
demonstrated that the majority of the encapsulated fluorescent molecules were released from 
the PLGAac side. Thus, the electrospun PCL-PLGAac scaffolds demonstrated the capability of 
confining sustained molecule release to one side of the scaffolds.  
The separation efficiency of Rh123 between the two surfaces (SRh123_B-A) of the PCL-
PLGAac scaffolds was 81 ± 5 % during 16-day release experiment. On the contrary, PCL-PLGAes 
samples displayed a mixed release behavior. Figure 3-7c showed that more molecules were 
released from the PCL side, when compared to PCL-PLGAac. In addition, after day 3, the 
molecule concentration measured on the PCL side exceeded that on the PLGAes side. This 
resulted in an overall separation efficiency of around 50%; thus, no separation of Rh123 
between the two surfaces of the PCL-PLGAac scaffolds was found.  
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Figure 3-7. Double-sided release test on PCL-PLGAac and PCL-PLGAes with Rh123 
impregnated in the PLGA fibers. (a) Schematic illustration of the custom-made diffusion 
chambers with independently sealed reservoirs facing the two surfaces of the electrospun 
samples. (b) Release of Rh123 from the two surfaces of PCL-PLGAac scaffolds. (c) Release of 
Rh123 from the two surfaces of PCL-PLGAes  scaffolds. The release was determined by 
measuring the fluorophore concentration in the chamber reservoirs. Herein, “Side B” indicates 
the fluorophore-loaded PLGA surface and “Side A” indicates the PCL surface.  
Therefore, the PCL-PLGAac scaffold was chosen for the release of biomolecules; though 
interesting, PCL-PLGAes scaffolds were not further used to study spatially-controlled protein 
release. 
A          B 
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3.3.4 Spatially-controlled protein release from PCL-PLGAac scaffolds 
A variety of micropatterned composite scaffolds made up of PCL nanofibers and protein-
impregnated PLGAac nanofibers were designed to demonstrate the use of nanofiber 
micropattern for spatially-controlled, sustained releases of single or dual molecules. PLGAac 
nanofibers loaded with fluorescently-labeled albumins were prepared by one-phase, solution 
electrospinning. Albumin was dissolved directly in the polymeric solution prior to 
electrospinning and appeared to be homogeneously distributed in the PLGAac nanofibers 
(Figure 3-9). 
50 µm50 µm
 
Figure 3-8. Optical and confocal images of PLGA nanofibers prepared by one-phase, solution 
electrospinning. Fluorecently-labeled, AlbF was dissolved directly in the polymeric solution 
and was homogeneously distributed along the nanofibers. 
3.3.4.1 Spatially-controlled sustained release of one molecule 
Figure 3-9 demonstrates the cumulative release of AlbT from the PCL-PLGAac 
electrospun scaffolds. The scaffolds were prepared according to the micropattern presented in 
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Figure 2. AlbT was encapsulated in the PLGAac nanofibers. The scaffolds were characterized by 
a nanofiber gradient and thus AlbT gradient. Results showed that sustained release of AlbT was 
highly confined to the PLGAac side of the scaffolds (Side B), and the release of AlbT from the 
PCL surface (Side A) was limited. The separation efficiency for AlbT between side B and side A of 
PCL-PLGAac scaffolds was 90 ± 4%, higher than the efficiency for small molecules (i.e. 
fluorophores). Results also showed that approximately 88% of the total amount of entrapped 
AlbT was released during the 50-day experiment.  
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Figure 3-9. Cumulative release of AlbT from the two surfaces of PCL-PLGAac composite 
scaffolds. The scaffolds were prepared following the compositional pattern presented in 
Errore. L'origine riferimento non è stata trovata.. AlbT was encapsulated in PLGAac and it 
was released mainly from the PLGAac-rich side.  “Side A” refers to the PCL-rich side, whereas 
“Side B” refers to the AlbT-loaded PLGAac side. 
This estimation was made using an overall PLGAac content in the scaffold equal to 48%, 
as obtained from DSC analysis of this specific AlbT-loaded PCL-PLGAac scaffold. Approximately 
20% of the total loaded proteins were released in the first 24 hours, 80% were released in 9 
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days. After day 9, the low-slope release curve indicated a small amount of sustained release at 
a constant rate (about 1% per week). In addition, it was found that the release rates on the two 
sides of the scaffold were similar after day 9.  
 
3.3.4.2 Controlled releases of dual molecules to one side 
Using electrospun scaffolds with a similar compositional micropattern as shown in 
Figure 2d, we also demonstrated the concurrent release of two proteins from the same side of 
the PCL-PLGAac composite scaffolds. Instead of dye-impregnated nanofibers, as illustrated in 
Figure 3-10a, PLGAac nanofibers in the inner part of the scaffolds were loaded with AlbF 
(green), while those in the outer region were loaded with AlbT (red). Results of cumulative 
release curves (Figure 3-10b-c) showed that both AlbT and AlbF were preferentially released 
from one side of the scaffolds with high efficiency. The separation efficiencies of AlbT and AlbF 
were 91 ± 4% and 87 ± 5%, respectively. To compare the release kinetics of AlbT and AlbF 
during the first 10 days, the cumulative release on Side B was normalized with respect to the 
respective total amount of delivered proteins (Figure 3-10d). The curves suggested that AlbF 
initially was released at a slower rate when compared to AlbT which was located closer to the 
surface, but the differences were not statistically significant.  
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Figure 3-10. Dual-drug release from one surface of the scaffold. (a) Illustration of the 
compositional pattern of nanofibers. (b) Cumulative release curve of AlbT. (c) Cumulative 
release curve of AlbF. (d) Comparison of AlbF and AlbT release during the first 10 days. 
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3.3.4.3 Controlled releases of dual molecules to the opposite sides 
The compositional gradient micropattern was further used as building-blocks of a more 
complex scaffold design for bi-directional release-control purposes. As illustrated in Figure 10a, 
the new pattern was generated by duplicating gradient patterns on both sides symmetric with 
respect to PCL. Herein, PLGAac was used to encapsulate either AlbF or AlbT. The designed 
pattern consisted of a 25 µm-thick layers of PLGAac electrospun nanofibers loaded with 
different fluorophore-tagged molecules on both surfaces, a 50 µm layer of PCL nanofibers in 
the core of the scaffold, and two PCL-PLGAac inter-layers characterized by a similar 
compositional gradient pattern. As a result, a precisely-controlled distribution of two 
biomolecules was generated across the scaffold thickness. Results from molecule release 
showed that AlbF and AlbT were selectively released from the opposite sides of the PLGAac-
PCL-PLGAac composite scaffolds. The cumulative release curves for AlbF and AlbT are shown in 
Figure 3-11b and Figure 3-11c, respectively. AlbF was predominantly delivered to the reservoir 
on Side A, while AlbT was released to that on Side B. The separation efficiency of AlbF between 
Side A and Side B (SAlbF_A-B) was equal to 0.91 ± 0.04, while the separation efficiency of AlbT 
between Side B and Side A (SAlbT_B-A) was equal to 0.92 ± 0.03. 
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Figure 3-11. Dual-drug release from the opposite surfaces of the PLGAac-PCL-PLGAac scaffold. 
(a) Illustration of the compositional pattern of nanofibers. (b) Cumulative release curve of 
AlbT. (c) Cumulative release curve of AlbF. Release of green-emitting AlbF was mainly 
confined to side A, whereas release of red-emitting AlbT is mainly confined to side B. 
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3.4  Discussion 
This study has developed and characterized a hierarchically-structured biomaterial 
platform, in which tunable nanofiber micropatterns are designed to control spatio-temporal 
release of molecules. Herein, the molecule release from the materials was illustrated with 
electrospun scaffolds whose micropattern over the thickness was characterized by 
complementary density gradients of diverse molecule-impregnated fibers. The scaffolds consist 
of PLGA fibers, an “active” component that encapsulates and releases model molecules, and 
PCL fibers, a “passive” component that provides mechanical integrity of the structure and 
sequesters molecule release. Various compositional patterns were designed and imaged with 
confocal microscopy which demonstrated good correlations between the designed and actual 
patterns. Additionally, we have revealed the differences of PLGAac (acid terminated PLGA) and 
PLGAes (ester terminated PLGA) during degradation, by showing that PLGAac is more stable 
and PLGAac nanofibers more gradually increase the diameter during hydrolytic degradation. 
Thus, spatially-confined release was demonstrated with PCL-PLGAac scaffolds but not PCL-
PLGAes scaffolds. Using the precise graded composition and the interplay between PCL and 
PLGAac, we showed that the hierarchically-structured composite was capable of sustaining 
selective release of small molecules or larger proteins on one side of the scaffold.  
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3.4.1 Selection of PLGA material for controlled release 
PLGA is a biodegradable polymer that has been used in a wide range of medical 
implants, tissue engineering products and drug delivery devices, because of its slow 
degradation, good biocompatibility and mechanical property [50–52]. Also, both PLGAac and 
PLGAes are often used for preparing degradable scaffolds or controlled release materials; 
however, no studies have examined the influence of their chemistry difference on their 
capability of encapsulating and releasing molecules. Different from previous studies, this study 
is the first to compare the use of low-molecular-weight PLGAac and PLGAes nanofibers for 
controlled release. There were large differences between the two PLGA materials in 
physiochemical properties and nanofiber morphology alterations during degradation. Our 
results suggested that these differences could be attributed to the polymer state transition as 
determined from the DSC thermo-analysis. PLGAes nanofibers changed dramatically since the 
beginning of degradation, lost fibrous features, and turned into a dense, continuous polymeric 
film in a week. Conversely, PLGAac nanofibers showed delayed morphological changes to much 
later stages of degradation. The rapid morphological evolution of PLGAes nanofibers can be 
explained by the fact that the onset point of the glass transition transformation for PLGAes 
(35.2°C) was lower than the experimental temperature (37°C). Although the glass transition 
temperature of PLGAes as measured from the inflection point of the DSC curve was 38.5°C, vast 
regions of PLGAes nanofibers undergo glass-rubber transitions at 37°C. Due to the phase 
transition, highly mobile polymer chains in the rubbery state allow polymer relaxation and 
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water uptake. Acting as the plasticiser, the water molecules could contribute to further 
reduction of the glass transition temperature of PLGAes. PLGAes also underwent chemical 
breakdown during degradation, showing immediate reduction in molecule weight. Increased 
mobility of polymer chains caused nanofibers to start soldering together at their junctions and 
then coalesce to form a continuous film. In contrast, PLGAac whose glass transition onset point 
was at 37.8°C, resulted in more stable nanofiber morphology. The glass-rubber transition likely 
was deferred, preventing water uptake. The PLGAac fibrous structure thus retained for a longer 
time, showing open, interconnected pores during degradation. The structural characteristics 
likely contributed to different behaviours of PCL-PLGAes and PCL-PLGAac in controlling release 
of molecules impregnated in the PLGA fibers, as shown in the results. The early formation of 
continuous, non-porous PLGAes layer might reduce the diffusion of biomolecules toward the 
PLGA surface, resulting in no confined release of Rh123 from PCL-PLGAes scaffolds after day 2, 
while PCL-PLGAac scaffolds maintained sustained, spatially-controlled molecule release over a 
6-week long period. Therefore, molecule release from the nanofiber composite scaffold is 
largely determined by the degradation behaviours and morphological changes of PLGA fibers.  
3.4.2 Sustained, spatially-confined molecule release  
Release of fluorescently-labeled albumin from PCL-PLGAac composite scaffolds were 
monitored up to 50 days in our study. Our prolonged release study demonstrated fast release in 
the first 9 days and limited amount of sustained release over the rest of the experimental 
period. In particular, the release profile of albumin showed modest burst release (~20% of total 
amount) on the first day. The initial burst release and subsequent fast release during the first 
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few days could be attributed to: (a) the nanofiber gradient pattern, in which higher density of 
molecule-impregnated fibers is closer to the surface for earlier release, and (b) the molecule 
distribution in the nanofiber. As suggested by previous studies, direct dissolution of molecules 
in the pre-spinning organic solution, as used in this study, could result in a non-uniform 
distribution of molecules with a large portion segregated at the nanofiber surface [140]. 
Therefore, modifications of temporal release kinetics might be approached by altering either 
the fiber pattern or the molecule encapsulation in the nanofiber. Encapsulation techniques 
other than one-phase blending might result in different release kinetics [141], [142]. Different 
from the molecule diffusion in the initial stage, the prolonged slow release in the later stage of 
the assay in this study may be attributed to the polymer degradation behaviour.  
In addition to sustained release, our release profiles of single small molecules or larger 
proteins as well as multiple proteins all demonstrated high separation efficiency of molecule 
release on the side with higher molecule concentration. Diffusion to the side with lower or zero 
concentration of molecules was minimal. The distribution of molecule-impregnated PLGAac 
nanofibers was thus effectively translated to sequestration of molecule release. The 
compositional gradient across the scaffold thickness confined molecule release in the proximity 
of a surface of the scaffold, thus leading to a spatially-defined preferential release. In addition, 
our results suggested that the rate of water penetration in the scaffold may strongly influence 
release profiles and distribution. However, further explorations are required for a better 
understanding of the water penetration/drug transport coupled phenomena.  
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3.4.3 Release mechanisms 
The most important mechanisms governing molecule release from polymeric scaffolds 
are diffusion, degradation and erosion of the polymer matrix [143], [144], [145]. To understand 
the underlying mechanisms, several mathematical models of mass transport have been 
developed. In this study, because PLGAac nanofibers exhibited modest swelling, the polymer 
molecular weight remained unchanged and the weight loss was small during the first week, 
diffusion was likely the leading mechanism of molecule release from PLGAac nanofibers during 
this period of time. A simple semi-empirical model proposed by Ritger and Peppas in 1986 
describes drug release behavior from polymer by taking into account both Fickian and non-
Fickian diffusion mechanisms, and is mathematically written as 
 
                 
ntM kt
M
∞
=                                                                                               (Eq 1) 
 
where Mt is the mass of drug released at time t, M∞ is the mass of drug released as time 
approaches infinity, k is a constant that incorporates characteristics of the polymer and the 
drug, and n is the diffusional exponent, which reflects the transport mechanism. Using Eq 1 to 
model our experimental data, we found this model was valid for the first 60% of the fractional 
release. Electrospun nanofibers can be modeled as a random array of mono-dispersed cylinders 
with diameters much smaller than their lengths. According to Ritger and Peppas, one-
dimensional radial release from a cylinder, under perfect sink conditions, can be described with 
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pure Fickian diffusion using Eq 1 (n = 0.45). For n = 1, drug release is independent of time (zero-
order release); for 0.45 < n < 1, drug release follows a non-Fickian anomalous transport 
mechanism. In this study, we showed that loaded molecules were released unevenly from the 
two surfaces of the scaffold. Approximately 90% of the total drug released in 50 days was 
delivered to one side of the scaffold. The release from the other surface was close to zero in the 
first week of the experiment and could be neglected. By fitting the first 60% of the release 
profile of AlbT from side B of PCL-PLGAac scaffolds (Figure 8), we obtained n equal to 0.59 ± 
0.07, with a high correlation coefficient (r
2
 = 0.983). The curves were normalized with respect to 
the total amount of loaded drug. Because diffusion is largely dependent on the water 
permeation through pore-to-pore movement in the non-uniform scaffold, release of molecules 
impregnated in PLGA fibers may be activated at different time points according to the location 
in the scaffold. In addition, due to the high surface-to-volume ratio of electrospun materials, 
the molecule distribution in the nanofibers may significantly influence the release. Herein, the 
use of one-phase molecule dissolution yielded a large amount of molecules on the surface of 
nanofibers [140], which was likely released during the first day and thus could be separately 
modeled. Excluding the first day data resulted in a much lower “n”, 0.46 ± 0.04, with a higher r
2
, 
0.998. The value of the diffusional exponent “n” was close to the theoretical value of 0.45. In 
light of the modeling results, we can divide the release profiles in three regions, based on the 
widely-used release mechanism. In the first day of the experiment, a modest burst release of 
about 20% of the total loaded molecules was obtained due to the molecules segregated near 
the nanofiber surface. Between day 2 and day 8, the scaffold released additional 60% of the 
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loaded molecules by Fickian diffusion. After day 9, the steady release of AlbT with a constant 
rate was found, which could resulted from PLGAac degradation and nanofiber swelling.  
3.4.4 Potential applications for regenerative scaffolds 
A new generation of scaffolding materials for tissue engineering and regenerative 
medicine seeks to combine the material scaffolding function such as structural guidance and 
mechanical support with the regenerative function such as molecule release to guide cell 
dynamics and organization [92]. We thus demonstrate a promising scaffolding biomaterial using 
programmable nanofiber structure to meet various mechanical and biological needs [43] 
Because tissue regeneration is a highly regulated process involving differentiation and spatial 
organization of multiple cell types in 3D, sustained release of cell-specific molecules in a 
spatially-defined arrangement, as demonstrated here, could spatially guide cells and their 
commitment to regeneration. Uniform presentation of a regenerative molecule may not satisfy 
regeneration needs in many situations [146], because over-expression of a regenerative 
molecule at a wrong place or a wrong time may lead to abnormal or diseased tissues. For 
example, PDGF is an important growth factor stimulating vascular SMC ingrowth and 
proliferation to build vascular medial layer, but it is also a major contributor to vascular intima 
dysfunction leading to intima hyperplasia and stenosis. Also, in some circumstances, 
biomaterials need to interface different tissues to stimulate regeneration [147]. 
Though we have demonstrated the potential of micropatterned nanofiber composite 
scaffolds using model fluorescent-labelled molecules or proteins, the material platform 
developed here can be applied to a wide range of applications, including therapeutic implants, 
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tissue engineering, and drug delivery. In these applications, spatial confinement and temporal 
control of various molecules are pivotal to the improvement of therapeutic efficacy and the 
reduction of biomolecule toxicity or side effects. Additionally, the gradient pattern structure 
could be further used as a building-block to design more complex molecule-fiber structures for 
spatially-defined, sequential release of multiple biomolecules. To achieve more complex 
structures or designs, one can take advantage of the programmable nanomaterial fabrication 
developed here, which involves separate control over the fabrication of different nanofibers 
and their positions in 3D. Because the bioactivity of proteins is a critical issue in the controlled 
release, future studies should involve the use of more environment-sensitive molecules. 
Electrospinning of molecule-impregnated nanofibers using a simple solution-based method as 
demonstrated here, has been used to release bioactive growth factors [39]. Also, other 
molecule encapsulation methods have been developed for electrospun materials to retain 
protein bioactivity [46], [141], [142], which might be used in conjunction with the techniques 
developed here in the future.  
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3.5 Conclusion  
We have developed and characterized micropatterned nanofiber composites made from 
biodegradable materials. This is the first demonstration of using nanofiber patterns in 3D 
biomaterials to achieve sustained, spatiotemporally-controlled release of multiple molecules or 
proteins. The hierarchically-structure composite may be used to define 3D dynamic 
microenvironments and likely find broader applications in tissue engineering and therapeutic 
device.
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4 PROGRAMMABLE DUAL-RELEASE PROFILES OF 
MODEL PROTEINS FROM ELECTROSPUN GRADED 
MATERIALS 
 
4.1 Introduction 
Nanofibrous scaffolds have demonstrated excellent potential for guiding the formation 
of new tissues in many tissue engineering fields [148–150]. In recent years, the regenerative 
potential of scaffolding materials has dramatically improved by encapsulation and release of 
proper biochemical signals in a controlled manner. Therefore, there is a great interest in 
developing scaffolds with the capability of selectively exposing cells and tissues to an 
assortment of active molecules with controlled dosage, timing and duration. Effective interplay 
between scaffolding materials and controlled release strategies is critical. In general, scaffold 
functions of can be extended to the delivery of signaling molecules either by using drug 
releasing scaffold or by incorporating drug delivery devices into the scaffold itself [151,152].  
Bulk- and surface-eroding polymeric devices can serve as programmable drug delivery 
systems to generate pulsatile release of one protein or sequential release of multiple 
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biomolecules. Effective multipulse drug delivery system has been demonstrated using materials 
based on resorbable polyesters [153,154], polyanhydride-based laminates [155] and crosslinked 
hydrogels [156]. Chen and Mooney [157] developed PLGA scaffolds for spatially confined 
delivery and sequential release of VEGF and PDGF; Suciati et al. demonstrated the release of 
different bioactive molecules by sintering alternative layers of drug-loaded PLA microparticles 
plasticized with PEG and unloaded microparticles [158]. Alternatively, PLGA microparticles have 
been used to obtain delayed release after an initial lag-time [92]. In addition, several drug 
delivery materials have been recently developed for dual GF delivery. Burdick et al. 
demonstrated dual release of GFs for neural regeneration by encapsulating PLGA microspheres 
loaded with NT-3 in a PLA-PEG-PLA hydrogel with free CNTF [159]. Instead, porous scaffolds 
were shown that promoted neo-vascularization as a result of the release of known pro-
angiogenic GFs, such as VEGF and PDGF [160]. 
In the previous chapter, we designed and established a material platform with 
electrospun composite scaffolds consisting of PCL and PLGA nanofibers with the ability to 
selectively deliver model biomolecules to one side of the scaffold. A precise gradient of 
composition through the scaffold thickness was created, which allowed one to tailor the initial 
distribution of small molecules and fluorescent-labeled proteins inside the device. We 
demonstrated that encapsulated molecules were released from one side of the scaffold with 
high efficiency of separation. We demonstrated that the composite structure could serve as a 
building-block to generate complex multilayered devices for controlled release of multiple 
biomolecules. This chapter thus further illustrates how different patterns and kinetics of release 
of two separate biomolecules can be achieved just by combining two of the basic elements. We 
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also seek to better understand the mechanism of the controlled release by providing the 
evidence about the critical role of PCL nanofibers in limiting water permeation in the scaffold 
for modulating the release pattern.  This is then applied to guide the design of new composite 
scaffolds with the capability of control the timing and the kinetics of molecule release. 
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4.2 Experimental part 
4.2.1 Materials and preparation of multi-component, electrospun scaffolds 
As described in the previous chapter, Poly(d,l lactide-co-glycolide) acid (PLGA) with a 
50:50 ratio of lactide/glicolide and a carboxylate end group from LACTEL
®
, was selected as the 
carrier for fluorescein isothiocyanate conjugate bovine serum albumin (AlbF, green emission) 
and Tetra-methyl-rhodamine isothiocyanate conjugate bovine serum albumin (AlbT, red 
emission). Poly-ε-caprolactone (PCL, 80 kDa) from Sigma Aldrich (St Louis, MO) and PLGA 
solutions with ALbF and AlbT were electrospun with a double electrospinning apparatus to 
obtain scaffolds with gradients of composition though their thickness. Electrospun nanofibers 
of pure PLGA were also prepared from PLGA solution without loaded molecules. Rhodamine B 
(RhB) was used as a fluorescent marker to study water penetration through electrospun 
scaffolds. Details about fluorescent molecules, solution preparations for electrospinning and 
parameters for the electrospinning process are provided in the previous chapter (please refer 
to sections 3.1, 3.2 and 3.3 of Chapter 3). Electrospinning conditions of PLGA were slightly 
modified to overcome the problem of unreliable spinning conditions at low flow rate, by 
limiting the duration of the spinning stages at the lowest rates. 
The electrospun composite materials with internal compositional gradients were 
prepared through sequential and/or simultaneous electrospinning of PCL and drug-loaded PLGA 
on a rotational mandrel collector. A previously described double-electrospinning system was 
used. In some cases intermixed layers of PCL and pure PLGA were integrated in the design to 
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modify water diffusion characteristics of the scaffolds. In general terms, electrospun structures 
consisted of layers of single polymer nanofibers and layers of mixed nanofibers made of 
different polymers. Fibers in different layers were obtained through the continuous spinning 
process following the designed micropatterns, in order to integrate materials with variable 
composition and uneven distribution of biomolecules inside the scaffold. More details of the 
compositional profile and the biomolecule distribution along the thickness of the different 
scaffolds are given in the Results section. The double-side molecule release was described in 
section 3.3 of chapter 3.  
4.2.2 Water permeation into the scaffolds 
PCL and PLGA were individually electrospun to prepare mats with an uniform 
composition. Circular samples were obtained with a 25 mm punch cutter from each electrospun 
net and were placed between 2 cylindrical chambers made out of PMMA to form a custom 
made diffusion cell. The actual thickness of all the samples was within 10% of the designed 
thickness. Each chamber, with 2.2 mm in diameter and 2 ml in volume, was sealed to one side 
of the scaffold with bi-adhesive rubber gasket. Small holes were drilled on the side of the 
PMMA chambers and were used to add or remove the liquid from the diffusion cell. The 
chamber on one side of the scaffold, or named sink reservoir here, was filled with phosphate 
buffer solution; the other chamber, or named source reservoir here, was filled with a 
concentrated solution of RhB in phosphate buffer (2 mg/ml). With predetermined intervals, 200 
µl of solution were withdrawn from the sink reservoir and replaced with fresh medium. The 
collected medium was analyzed for RhB concentration with a microplate spectrophotometer. A 
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total of 4 PCL disks and 6 PLGA disks were tested. The results were expressed as average ± 
standard deviation. 
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4.3 Results and Discussions 
In this study, we designed electrospun scaffolds for controlled release of multiple active 
molecules. In the previous chapter, we demonstrated electrospun scaffolds with variable 
composition and graded micro-patterns of nanofibers along the thickness of the scaffold. We 
also demonstrated that electrospun scaffolds were capable of confining the release of model 
proteins to one side of the materials. Herein, we aimed to study whether the spatial patterns of 
nanofibers had the capacity of programming release kinetics. By using the basic patterns 
developed before as building blocks, we engineered the scaffolds for various release patterns. 
This was done through modifying the distribution and proportion of PCL and PLGA nanofibers 
along the thickness of the scaffold. The newly designed scaffolds maintained the ability to 
localize the delivery of each loaded biomolecule and demonstrated the capability of controlling 
the release kinetics.  
4.3.1 Sequential release  
Using PCL as the matrix, electrospun composite scaffolds with dual PLGA gradient 
patterns were designed for the sequential release of two proteins. The materials were prepared 
by continuous electrospinning in sequence of a 50 µm-thick layer of PCL nanofibers, a mixed 
layer of PCL and AlbF-loaded PLGA nanofibers with varied PCL/PLGA ratios, a 25 µm-thick 
transitional layer of PCL nanofibers, and a mixed layer of PCL and AlbT-loaded PLGA nanofibers 
with varied PCL/PLGA ratios. Figure 4-1a shows a schematic illustration of the pattern. The 
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micro-pattern was characterized by an equal amount of AlbF-loaded PLGA and AlbT-loaded 
PLGA, and consequently, an equal amount of AlbF and AlbT. The overall composition was 55% 
(wt) of PCL, 22.5% (wt) of AlbF-loaded PLGA and 22.5% (wt) of AlbF-loaded PLGA.  
 
Figure 4-1b showed the cumulative release profiles of AlbF and AlbT released from both 
sides of the scaffold. It was found that both AlbF and AlbT were delivered preferentially to the 
chamber on side B. The separation efficiencies of AlbF and AlbT between side B and side A were 
0.92 ± 0.03 and 0.85 ± 0.04, respectively. The scaffold was highly efficient in spatially confining 
the delivery of both AlbT and AlbF. The spatial confinement was more efficient for AlbT than for 
Alb F. AlbF was also released mainly on side B, although it was originally localized in a central 
region of the scaffold. Daily net release of AlbF and AlbT to side B in the first 12 days were 
shown in Figure 4-1c. The release kinetics of AlbF and AlbT are different from the previous 
study on dual protein release in Chapter 3. The net release of AlbT peaked on day 1 and day 2, 
and the net release of AlbF peaked on day 5.  
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Figure 4-1. PCL-PLGA scaffold for the sequential release of proteins. (a) Illustration of the 
compositional pattern of nanofibers. AlbF-loaded PLGA nanofibers were confined in the 
middle of the scaffold, while AlbT-loaded PLGA nanofibers were close to side B; (b) Cumulative 
release profiles of AlbF and AlbT from the two surfaces of the scaffold; (c) Net release profiles 
of AlbF and AlbT to side B during the first 12 days 
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Furthermore, to explore the effect of the material pattern on the spatio-temporal 
release kinetics, a scaffold structure of modified dual gradients for the sequential release was 
designed (Figure 4-2a).  
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Figure 4-2. PCL-PLGA scaffold with PLGA in the transitional layer of the pattern to modify the 
sequential release of proteins. (a) Illustration of the compositional pattern of nanofibers. 
PLGA and PCL nanofibers were combined in the transition zone between AlbF-loaded PLGA 
and AlbT-loaded PLGA nanofibers. (b) Net release profiles of AlbF and AlbT to both sides 
during the first 12 days 
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In the modified design, the 25 µm-thick transitional layer of PCL nanofibers was 
replaced by a layer of intermixed PCL and PLGA nanofibers (PCL/PLGA ratio of 50/50). 
Compared to Figure 1, the release profile for AlbF was different: the net release of AlbF to side 
B peaked on day 3, much earlier than the similar pattern without PLGA in the transitional layer 
(Figure 4-2b). Meanwhile, the ability of the scaffold to confine the release on one specific side 
remained unaffected.  
Therefore, various release kinetics of combined biomolecules could be achieved by 
modulating the nanofiber micropattern and the composition profile including the thickness of 
the PCL layer, thickness and composition of transitional layer. Regulating the timing and release 
kinetics of different molecules from scaffolds is critical to successful tissue regeneration. For 
example, there are different molecules influencing the process of neovascularization at 
different stages. In particular, VEGF contributes to initiate angiogenesis, while PDGF promotes 
vessel maturation in a later stage [161], [162]. For this reason, porous PLGA scaffolds for the 
sequential release of VEGF and PDGF were prepared by subsequently entrapping PDGF-loaded 
nanoparticles and integrating free VEGF into a scaffold by gas foaming and particulate leaching 
[160]. The nanofiber-based materials developed here may more readily program the desired 
molecule release kinetics for regeneration of mechanically strong tissues such as artery. For 
instance, it has been shown that PDGF guide the migration of smooth muscle cells, while 
transforming growth factor beta (TGF-β) is able to accelerate the proliferation of smooth 
muscle cells. 
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 A sequential release of PDGF and TGF-β with proper timing (Figure 4-3) may promote 
regeneration of arterial media.  
 
                    
Figure 4-3. Schematic illustration of a possible pattern for the sequential release of PDGF and 
TGF-β to regenerate vascular media.  
Currently, the optimal release kinetics for tissue regeneration in vitro or in vivo is largely 
unexplored. Using scaffolds to program release kinetics as demonstrated here, could be 
instrumental to identify an optimal condition from a large variety of release patterns and to 
study the underlying molecule mechanism. In addition, this method could be applied to the 
preparation of drug delivery devices for pulsatile release of active molecules. 
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4.3.2 Dual molecule release to the opposite sides of a scaffold 
In order to demonstrate the effect of nanofiber composition on spatial control over 
biomolecule release from the scaffold, we have modified the pattern for dual molecule release 
to the opposite sides of a scaffold, which was demonstrated in Chapter 3. As shown in Figure 
4-4a, the modified pattern comprised a 25 µm-thick layer of AlbF-loaded PLGA electrospun 
nanofibers on one surface of the scaffold, an inter-layer of PCL and AlbF-loaded PLGA with 
variable composition, a 50 µm-thick transitional layer of intermixed PCL and PLGA nanofibers in 
the core of the scaffold, an inter-layer of PCL and AlbT-loaded PLGA with variable composition, 
and 25 µm-thick layers of AlbT-loaded PLGA electrospun nanofibers close to the other surface. 
The micro-pattern was characterized by an equal amount of AlbF-loaded PLGA and AlbT-loaded 
PLGA, and consequently, an equal amount of AlbF and AlbT. The material composition was 35% 
(wt) of PCL, 25% (wt) of AlbF-loaded PLGA, 25% (wt) of AlbF-loaded PLGA and 15% (wt) of PLGA. 
Overall, the scaffold consisted of 65% of PLGA nanofibers and 35% of PCL nanofibers. 
The cumulative release curves for both AlbF and AlbT were shown in Figure 4-4b and 
Figure 4-44c, respectively. The separation efficiency of AlbF between side A and side B (SAlbF_A-B) 
was 0.82 ± 0.04, while the separation efficiency of AlbT between side B and side A (SAlbT_B-A) was 
0.81 ± 0.05.  
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Figure 4-4. PCL-PLGA scaffold with PLGA in the transitional layer of the pattern to modify the 
spatially-controlled release of proteins. (a) Illustration of the compositional pattern of 
nanofibers. PLGA and PCL nanofibers were combined in the transition zone between AlbF-
loaded PLGA and AlbT-loaded PLGA nanofibers. (b) Cumulative release profiles of AlbF to both 
sides of the scaffold; (c) Cumulative release profiles of AlbT to both sides of the scaffold. 
 
As shown in the previous chapter (Chapter 3, Section 3.4), when the transitional region 
consisted of only PCL nanofibers, the separation efficiencies of AlbF and AlbT (SAlbF_A-B and 
SAlbT_B-A) were 0.91 ± 0.04 and 0.92 ± 0.03, respectively. Here, we showed the scaffold pattern 
with the presence of a considerable amount of PLGA nanofibers in the transitional layer 
retained the ability to confine the protein release to one side, but the separation efficiency was 
significantly reduced. This molecule-releasing scaffold may be used in the applications where 
coordination of different molecule activities is needed. In the last 10 years, electrospun 
scaffolds have been explored for a number of applications such as wound dressing materials, 
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anti-adhesion membranes, vascular and cardiac patches, vascular grafts, neural conduits and 
repair of osteochondral defects. In these applications, the materials often interact with 
different cells, tissues and even organs. Scaffolds that selectively provide proper biochemical 
cues to different cell populations on two surfaces of the scaffolds may help simultaneous and 
coordinated regeneration of tissues. In the case of vascular tissue engineering, for example, a 
scaffold releasing VEGF and TGF-β respectively to the two surfaces, as illustrated in Figure 4-5, 
might simultaneously promote the formation of an endothelial layer on one side while inducing 
the proliferation of smooth muscle cells on the other side. 
 
Figure 4-5. Schematic illustration of a possible pattern for the separate release of VEGF and 
TGF-β on different sides of a vascular graft to regenerate artery. The delivery of each growth 
factor is spatially confined to one of the opposite surfaces of the scaffold to meet the specific 
requirements of different cell populations. 
4.3.3 Delayed release of AlbF and AlbT from opposite sides  
To further modulate the release patterns for delayed protein release, another pattern 
with two symmetric compositional gradients inside the scaffold was designed and characterized 
(Figure 4-6a). In this design, the fraction of albumin-loaded PLGA nanofibers was higher in the 
internal region of the construct, rather than near the surfaces. Starting from side A, the 
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molecule delivery scaffold consisted of a 20 µm-thick layer of PCL nanofibers, an interlayer of 
mixed PCL and AlbF-loaded PLGA nanofibers with PLGA content varying from 0 to 0.8, a 50 µm-
thick transitional layer of intermixed PCL and PLGA nanofibers, a interlayer of mixed PCL and 
AlbT-loaded PLGA nanofibers with PLGA content gradually varying from 0.8 to 0, and a second 
20 µm-thick layer of PCL nanofibers on Side B. The scaffold contained equal amount of AlbF-
loaded PLGA and AlbT-loaded PLGA. As a result, the scaffold was composed of approximately 
40% (wt) of PCL, 22.5% of AlbF-loaded PLGA, 22.5% of AlbF-loaded PLGA and 15% of PLGA. 
Overall, the scaffold consisted of 65% of PLGA nanofibers and 35% of PCL nanofibers.  
The cumulative release curves for AlbF and AlbT are shown in Figure 4-6b and Figure 
4-6c, respectively. With this configuration, the scaffold maintained the ability to localize the 
release of each drug on one surface,  but the separation efficiency was dramatically reduced: 
SAlbF_A-B and SAlbT_B-A was reduced to 0.66 ± 0.05 and 0.63 ± 0.05, respectively. Also, it resulted in 
a different release pattern: a near-zero order release was obtained instead of a power law 
behavior. Compared to the release profiles shown before, the initial burst release on the first 
day dramatically diminished. The stage of fast release due to diffusion was also delayed and 
kept over a longer period.  
In general, we have demonstrated the capability of modifying the release kinetics with 
programmable the pattern and/or the fiber composition. Unfortunately, modulating temporal 
kinetics may reduce the spatially confinement of the molecule delivery to one side. However, 
this might be mainly due to the presence of PLGA nanofibers in the transitional layer along with 
PCL fibers. For the applications that require a high separation efficiency of a molecule to one 
side, a pattern without PLGA nanofibers in the transitional region is suggested.  
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Figure 4-6. Modified PCL-PLGA scaffold with inverse gradient for dual molecule release from 
opposite sides of the scaffold and in vitro release profiles of AlbF and AlbT from the two 
surfaces of the scaffold. a.) Schematic representation of a PCL-PLGA graded scaffold with two 
reversed gradients. The content of albumin-loaded PLGA nanofibers was 0 near the surfaces 
and maximum in the internal part of the scaffold. PLGA and PCL nanofibers were combined in 
the transition region between AlbF-loaded and AlbT-loaded PLGA nanofibers . Cumulative 
release curves for AlbF (b.) and AlbT (c.)  
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4.3.4 Mechanism of drug release 
In the previous chapter, we suggested that the protein release was divided into 3 stages: 
(1) the initial burst release on the first day, which resulted from a non-Fickian diffusion 
mechanism (anomalous diffusion); (2) the stage of fast release, which can be described by a 
semi-empirical equation developed by Rittger and Peppas using a network of mono-disperse 
infinite cylinders to model nanofibers; and (3) the final stage of steady slow release. Despite a 
number of approximations in the Rittger and Peppas equation, this approach has been widely 
used in order to describe the release behavior of electrospun nanofibers. However, the 
understanding of the molecular diffusion through the scaffold was still limited. The role of PCL 
nanofibers and the water diffusion or permeation into the scaffold remained unclear.  In this 
chapter, we thus designed and characterized several different scaffolds to better understand 
the regulatory mechanisms of release through nanofiber patterns. By comparing all the release 
profiles, we could reach the following conclusions:  
First, the integration of PLGA nanofibers and PCL nanofibers in the transitional regions 
of the scaffold resulted in a reduced capability of the scaffold to spatially confine the molecule 
delivery (Figure 4-4 and Figure 4-6). In other words, the diffusion of biomolecules, limited by 
PCL nanofibers, was expedited with the presence of PLGA nanofibers. In the case of sequential 
release, the movement of AlbF toward side B was faster in the presence of PLGA in the 
transitional region. 
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Second, when the fluorophore-labeled albumin is located close to the surface of the 
scaffold, a relatively faster release is obtained with a larger portion released in the first days 
(Figure 4-5). If albumin-loaded PLGA nanofibers are covered by a layer of PCL fibers, delayed 
release is found (Figure 4-1b, Figure 4-2b, Figure 4-6).  
Third, the thickness of the PCL layers is important. For example, as shown in Figure 4-1, 
a 50 µm-thick layer of PCL nanofibers almost completely prevents AlbF from releasing to side A, 
while a 25 µm-thick transitional layer of PCL nanofibers only delays the molecule diffusion 
toward side A. 
In summary, the role of PCL nanofibers that play in the pattern-controlled 
spatiotemporal  release is likely to prevent molecule diffusion, while PLGA nanofibers seems to 
favor the transfer of biomolecules. To study this hypothesis, we compared the water diffusion 
through PLGA nanofibers and PCL nanofibers (Figure 4-7). Macroscopically, we found that 
within less than two days, the appearance of a 150 µm-thick layer of PLGA nanofibers turned 
from white to completely translucent, a sign of complete water uptake.  Also, small molecules 
dissolved in the water can freely move from one side of the material to the other. On the 
contrary, in the case of PCL nanofibrous materials, no small molecules (RhB) were detected for 
almost 2 days in the sink reservoir, showing that there was no molecule movement between 
the opposite chambers. After 6 days, the concentration still increased slowly. Macroscopically, 
the material retained its white color. Therefore, the results suggested that water diffusion 
through a thin layer of PCL nanofibers was difficult. This is probably due to the hydrophobicity 
of PCL nanofibers, which hinder the movement of water molecules. 
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Figure 4-7. Water permeation into PLGA and PCL electrospun scaffolds. 
Because the molecule diffusion or release through the nanofibrous scaffold was via the 
water permeation, to fully describe the release behavior of the composite electrospun 
scaffolds,  both the molecule diffusion from the nanofibers and the water movement through 
the scaffold have to be taken into account. With a finite velocity of water uptake, the molecule 
diffusion and dissolution are activated at different time points in different scaffold regions. The 
diffusion pathways of the molecules toward the surface of the device are limited by the 
presence of air-filled pores. 
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4.3.5 Modeling the release 
A full understanding of the material performances could help to guide the design of 
programmable molecule delivery systems with desired release profiles. This will only be 
possible with the development or identification of a mathematical model that properly describe 
the release. This is a challenging task. Herein, we propose a possible modeling approach using a 
basic gradient pattern (Figure 4-8). 
 
 
Figure 4-8. Design pattern for composite scaffold with compositional and biochemical 
internal gradient  
The diffusion coefficient for water (Dwater) is required to describe the water movement 
in the scaffold. According to our experimental results, the diffusion coefficient of water in PLGA 
nanofibers (Dwater-PLGA) defines the higher end of Dwater, while the diffusion coefficient of water 
in PCL nanofibers (Dwater-PCL) defines the lower end of Dwater. Dwater-PLGA and Dwater-PCL can be 
determined from diffusion studies or derived from thermodynamic principles. As the 
micropattern is characterized by a gradient structure with varied PCL/PLGA ratios, Dwater varies 
with the composition in the intermixed layers of nanofibers. Thus, a linear relationship between 
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Dwater with the PCL/PLGA ratio or the position x over the scaffold thickness is expected. The rate 
of water uptake in the scaffold (w) at a specific time point can be determined with Eq.1.  
 
( )waterw d dwD xt dx dx
∂  
=  ∂  
        Eq. 1 
 
In alternative, we could also determine with the relationship with the percolation 
theory. The amount of encapsulated molecules in the scaffolds and the amount of mobile 
molecules at each time point may be quantified with Eq. 2 and Eq. 3, where K is a constant that 
depends on the molecule and the material. Eq. 2 describes the variation of encapsulated 
molecules in the scaffold, while Eq. 3 describes the rate of molecule release.  
 
fix
fixK wt
ρ ρ∂ = − ⋅
∂
         Eq. 2 
( ),mob fix d dwK w D x wt dx dx
ρ ρ∂  = ⋅ +  ∂  
      Eq. 3 
 
In summary, the dependence of the diffusion coefficient (D(x,w)) on the material 
composition point by point (x) and on the water content (w) has been used to describe the 
molecule diffusion in the scaffold. The diffusion problem can be solved with boundary 
conditions that depend on the specific compositional pattern and D(x,0) = 0, at t = 0. To our 
knowledge, there is no analytical solution for this problem, and thus a numerical solution 
should be expected.  
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4.4 Conclusions 
Taking advantage of multi-functional scaffolds produced by a double electrospinning, 
we demonstrated programmable drug delivery devices able to deliver different active 
molecules in a controlled fashion. We obtained simultaneous and sequential release of two 
different model proteins on the two surfaces of a newly engineered, composite electrospun 
scaffolds, and we showed that release kinetics can be influenced by changing the initial pattern 
of drug distribution and the composition of the scaffold. We believed that scaffold preparation 
and release micropatterns presented in this work may represent the platform for the 
development of novel multifunctional matrices able to control and direct the process of tissue 
regeneration. 
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5 SOLUTION AND EMULSION ELECTROSPINNING FOR 
VASCULAR ENDOTHELIAL GROWTH FACTOR 
ENCAPSULATION AND RELEASE  
 
5.1 Introduction  
In the previous chapters we presented a number of electrospun scaffolds with a 
potential as specialized drug delivery systems. We designed and prepared by electrospinning 
nanofibers mats characterized by a novel compositional and biochemical micropattern for 
encapsulation and release of biomolecules. By taking advantage of a smart distribution of 
encapsulated species and differential water penetration rates throughout the scaffold, we 
demonstrated spatially- and temporally-programmable delivery of model biomolecules, such as 
fluorescent dyes and fluorescently-labeled proteins. Previously in this thesis work, we used 
one-phase, solution electrospinning process to encapsulate model molecules in the nanofiber 
scaffolds; however, our findings can be extended to any encapsulation methods and any drug-
carrier polymers. The usage of different polymer/drug systems will result in different release 
rates and profiles of the specific loaded molecules, but the overall release scheme, involving 
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locally-confined and temporally-programmable deliveries, will be respected. In fact, the release 
profile of a particular drug depends just on the specific mechanism of release from nanofibers, 
while the overall release pattern depends essentially on the peculiar compositional pattern and 
the initial drug distribution that we designed.  
Growth factors (GF) are proteins specific for cell-to cell and cell-extra cellular matrix 
communication. During tissue morphogenesis GFs influence cellular behavior, tissue formation 
and organization. Growth factors are stored in the extra cellular matrix in insoluble, inactive 
forms via specific binding with glycosaminoglycans like heparins. Upon specific activation GFs 
are readily released in the intercellular fluid, where they can express their biological activity. 
Confinement of inactivated GFs within the ECM is an amazingly efficient solution for rapid, 
extracellular signal transduction. Concentration and spatial distribution in the extracellular 
environment are key factors for GFs efficacy. In particular, it has been shown that gradients in 
the concentration of free GFs can direct cell adhesion and migration, differentiation of 
multipotent cells and organization of cells into complex structure [163,164]. 
Vascular endothelial growth factor (VEGF) is a potent mitogen for micro- and macro-vascular 
endothelial cells and it is considered to be one of the most critical aspects in vascular formation 
and regeneration, particularly regulating the function of endothelium. Dosage of these 
biomolecules must be carefully regulated in a quantitative, spatial, and temporal manner in 
order to control cellular behaviors. Efficiently engineered VEGF delivery systems are required to 
minimize drug loss, degradation and denaturation, to assure a release within the concentration 
range in which the maximum benefit is provided. As VEGF has a short half-life in the body, a 
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smart drug delivery system have to maximize the medicament availability in the most required 
zone and limit the release in the near-by region [165].  
In one-phase, solution electrospinning biomolecules are directly mixed within the 
polymer solution, and  the mixed solution is electrospun to fabricate drug-loaded nanofibers. 
Researchers have used solution electrospinning to incorporate various types of proteins and 
genes in nanofiber scaffolds, including bovine serum albumin (BSA) [166], lysozyme [167] and 
growth factors [49]. Although solution electrospinning is relatively easy to perform, a possible 
issue with activity loss of incorporated biomolecules can arise. This is a quite severe problem 
for proteins, because they may lose their bioactivity due to conformational changes in the 
organic solution. For this reason, emulsion electrospinning has been proposed as an alternative 
technique for the preparation of drug-loaded nanofiber materials. Emulsion electrospinning is 
relatively novel and simple method of encapsulating biomolecules in biomaterials and has 
attracted increasing interest in the recent years [142,168]. It was also pointed out that 
nanofibers prepared by emulsion electrospinning could protect the structural integrity and 
bioactivity of encapsulated protein [166,168].  
In this part of the work we used both one-phase solution electrospinning and emulsion 
electrospinning to encapsulate VEGF in nanofiber scaffolds and we monitored VEGF release 
with a short-term in vitro release experiment. In addition, by using fluorescent molecules, we 
showed how the specific encapsulation method strongly influences drug distribution inside the 
nanofibers.  
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5.2 Experimental part 
5.2.1 Materials 
LACTEL® 50:50 poly(d,l lactide-co-glycolide) acid with a carboxylate end group and 
intrinsic viscosity of 0.67 dL/g, hereinafter referred to as PLGA, was purchased from DURECT 
Corp. (Pelham, AL, USA).  
RESOMER® R207S poly(d,l lactide) acid with inherent viscosity of 1.3 - 1.7 dL/g, 
hereinafter referred to as PdlLA, was obtained from Pharma Polymers (Darmstadt, Germany) 
Poly(ε-caprolactone) (PCL) with molecule weight of 80 kDa, chloroform (CF), N,N-
dimethylformamide (DMF), methylene chloride (MC), 1,1,3,3,3-hexaflouro-2-propanol (HFIP), 
as well as emulsifiers, Span
TM
 80 and Tween
TM
 80 were all purchased from Sigma Aldrich (St. 
Louis, MO, USA).  
Bovine serum albumin (BSA), fluorescein isothiocyanate conjugate bovine serum 
albumin (AlbF) with green emission and vascular endothelial growth factor human recombinant 
(VEGF) were also obtained from Sigma Aldrich (St. Louis, MO, USA).  
Quantikine® Human VEGF ELISA kit was purchased from R&D Systems (Minneapolis, 
MN, USA) and used for the quantitative determination of VEGF content in the release medium, 
kit following the manufacturer's protocol. 
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5.2.2 Preparation of pre-spinning solutions and electrospinning 
Protein-loaded electrospun PLGA and PdlLA nanofibers were prepared by conventional 
solution electrospinning. Flourescently-labeled albumin AlbF was encapsulated in PLGA and 
PdlLA nanofibers for visualization of the distribution of the loaded biomolecules. A solution of 
AlbF in DI water with a concentration of 5 mg/ml was prepared and then mixed with HFIP in a 
1:7 volumetric proportion. The HFIP:DI water mixture with AlbF was used to dissolve PLGA with 
a final concentration of 17% (wt) and PLGA nanofibers loaded with AlbF were prepared from a 
homogeneous, one-phase solution by solution electrospinning. Nanofiber mats prepared with 
this technique were indicated hereinafter as PLGAsol_AlbF. Electrospinning parameters for all 
the electrospun nanofibers prepared by solution electrospinning are listed inTable 5-1. 
The HFIP:DI water mixture with AlbF was also used to dissolve PdlLA to a final 
concentration of 10% (wt) and PdlLA nanofibers loaded with AlbF were prepared by solution 
electrospinning (hereinafter indentified as PdlLAsol_AlbF). Thin layers of PLGA and PdlLA 
electrospun nanofibers loaded with AlbF were deposited on glass slides for confocal 
observation.  
Lyophilized VEGF was reconstituted with DI water at a concentration of 0.1 mg/ml to 
prepare the VEGF batch solution. By dilution of the VEGF batch solution in DI water and 
addition of BSA powder, a 17 µg/ml VEGF solution in DI water with 5% BSA was obtained, and 
then mixed with HFIP in a 1:7 volumetric proportion. This mixture was used to dissolve PLGA to 
a final concentration of 17% (wt) and VEGF-embedded PLGA nanofiber nets were produced by 
solution electrospinning (hereinafter PLGAsol_VEGF-BSA). 
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Similarly, by dilution of the VEGF batch solution in DI water and addition of BSA powder, 
a 10 µg/ml VEGF solution in DIwater with 5% BSA was obtained, and then mixed with HFIP in a 
1:7 volumetric proportion. This new mixture was used to dissolve PdlLA to a final concentration 
of 10% (wt) and VEGF-embedded PdlLA nanofiber nets were produced by solution 
electrospinning (hereinafter PdlLAsol_VEGF-BSA). In addition, PCL was dissolved in 75/25 
CL/DMF at a concentration of 10% (wt).  
 
Polymer Samples 
Prepared 
Solvent  
system 
Polymer 
conc. 
[% wt] 
Voltage 
 
[kV] 
Work 
Distance 
[cm] 
Feed rate 
[ml/h] 
PLGA 
PLGAsol_AlbF 
HFIP/water 
7/1 vol. 
17 24 22 0.65 
PLGAem_AlbF 
CL-water-
emulsifier* 
10 24 18 0.5 
PLGAsol_VEGF-BSA 
HFIP/water 
7/1 vol. 
17 18 22 0.65 
PLGAem_VEGF-BSA 
CL-water-
emulsifier* 
10 18 20 0.5 
       
PdlLA 
PdlLAsol_AlbF 
HFIP/water 
7/1 vol. 
17 24 22 0.9 
PdlLAem_AlbF 
CL-water-
emulsifier* 
10 24 18 0.8 
PdlLAsol_VEGF-BSA 
HFIP/water 
7/1 vol. 
17 18 22 0.9 
PdlLAem_VEGF-BSA 
PCL-PdlLA_VEGF-BSA 
CL-water-
emulsifier* 
10 18 18 0.2-0.8 
       
PCL PCL-PdlLA_VEGF-BSA 
CF/DMF 
3/1 vol. 
10 26 24 0.3-1.1 
Table 5-1. Electrospinning parameters for the nanofiber mats prepared by solution and 
emulsion electrospinning (* Emulsion consisting of CL-water phase-emulsifier mixture with a 
100-5-2 volumetric ratio) 
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5.2.3 Preparation of the pre-spinning W/O emulsions and electrospinning 
Protein-loaded electrospun PLGA and PdlLA nanofibers were also prepared by 
electrospinning of a water-in-oil (W/O) emulsions. Electrospinning parameters for electrospun 
nanofibers prepared by emulsion electrospinning are also listed in Table 5 – 1.. 
A combination of Span80 and Tween80 (9 to 1 in volume) was used as emulsifier to 
stabilize the emulsions. The volume of the aqueous phase and the volume of emulsifier  were 
set to 1/20 and 1/50 of the volume of the organic solution, respectively. First, the organic phase 
and the emulsifier were homogenized  in a glass vial with a magnetic stirrer, then the aqueous 
solution was added drop-by-drop under constant stirring. A magnetic stirring bar rotating at 
1000 rpm was used for the emulsification process. A secondary stage of emulsification via 
ultrasonification was also considered. 
Flourescently-labeled albumin, AlbF was encapsulated in PLGA and PdlLA nanofibers 
prepared by emulsion electrospinning for the visualization of the protein distribution. A 2 
mg/ml solution of AlbF in DI water was emulsified with a 17% (wt) PLGA solution in CL. AlbF-
loaded PLGA nanofibers prepared by emulsion electrospinning are hereinafter indicated as 
PLGAem_AlbF.  
A 2 mg/ml solution of AlbF in DI water was also emulsified with a 11% (wt). AlbF-loaded 
PdlLA nanofibers prepared by emulsion electrospinning are hereinafter indicated as 
PdlLAem_AlbF.  
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W/O emulsions containing AlbF were examined with a confocal microscope to assess 
the distribution of the AlbF-marked dispersed phase (water phase) inside the continuous phase 
(polymeric organic solution). 
In addition, a 17 µg/ml VEGF solution in DIwater with 5% BSA was emulsified with a 17% 
(wt) PLGA solutions in CL. Similarly, a 10 µg/ml VEGF solution in DIwater with 5% BSA was 
emulsified with a 11% (wt) PdlLA solutions in CL. VEGF-loaded PLGA and PdlLA nanofiber 
materials produced by emulsion electrospinning of the previously prepared emulsions are 
hereinafter indicated as PLGAem_VEGF-BSA and PdlLAem_VEGF-BSA.  
5.2.4 PCL-PLGA and PCL-PdlLA graded scaffolds for spatially-confined release of 
VEGF 
PCL-PLGA and PCL-PdlLA composite scaffolds with a compositional and biochemical 
gradient along their thickness were also prepared (hereinafter PCL-PLGA_VEGF-BSA and PCL-
PdlLA_VEGF-BSA, respectively). VEGF-loaded PdlLA and VEGF-loaded PLGA nanofibers were 
electrospun by emulsion electrospinning of the corresponding emulsion prepared as indicated 
above. 
A schematic representation of a composite scaffold is reported in Figure 5-1. The 
scaffold was obtained following the design of the basic drug-delivering element already 
described and tested in Chapter 3. Please, refer to Chapter 3 for a detailed description of the 
micropattern, scaffold composition, the drug distribution and preparation procedures.  
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Figure 5-1. Schematic illustration of the cross-section of PCL-PdlLA_VEGF-BSA electrospun 
scaffold with internal compositional and biochemical gradient. 
5.2.5 Nanofibers characterization 
Nanofibers loaded with AlbF were examined as spun with a confocal microscope to 
assess the distribution of encapsulated molecules. The morphology of the electrospun fibers 
was observed using scanning electron Microscopy SEM. 
5.2.6 In vitro release of VEGF 
Phosphate buffer solution pH 7.4 used as release medium was prepared as indicated in 
Chapter 3, with the addition of 0.1% BSA.   
VEGF-loaded PLGA and PdlLA nanofiber materials prepared by solution and emulsion 
electrospinning (PLGAsol_VEGF-BSA, PdlLAsol_VEGF-BSA, PLGAem_VEGF-BSA and 
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PdlLAem_VEGF-BSA) were immersed in the BSA-enriched release medium to assess in vitro 
release of VEGF. Three pre-cut specimens, approximately 20 mg in weight, were obtained from 
PLGA and PdlLA mats prepared either by solution or by emulsion electrospinning. Each 
specimen was placed in a separate test tube, covered with 2 ml of 0.1% BSA phosphate buffer 
solution and placed at 37°C for 7 days, under mild agitation. For the PCL-PdlLA composite 
scaffolds (PCL-PdlLA_VEGF-BSA) the in vitro release test was performed using the diffusion cell 
and methodologies for side-by-side release tests previously described in Chapter 3. Using this 
release system, it was possible to discriminate between VEGF delivered to Side A and VEGF 
delivered to side B.  
Each day the supernatant was removed, the samples were briefly rinsed in DI water, and 
fresh release medium was added. Extracted samples were stored at -80°C, prior examination. 
VEGF content in the release medium was determined for elutions with the Quantikine® Human 
VEGF ELISA kit, following manufacturer’s specifications. To reduce the number of analyzed 
samples, elutions extracted from the three repetitions of each data point were mixed together 
prior examination; for this reason, the reported values represent the average value of the 
release and no error bars are provided.  
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5.3 Results and Discussions 
5.3.1 Preparation of stable W/O emulsions and electrospinning 
A number of water solutions were mixed with either PLGA or PdlLA solutions in 
chloroform and stable emulsions was obtained under agitation. The aqueous solution was 
added into the oily phase drop-by-drop to ensure the atomization of the aqueous phase. A 
mixture of Span80 and Tween80 was added into the polymer solution prior to emulsification as 
a surfactant to lower the surface tension of the oily phase. Tween 80 belongs to a class of food 
additives also known as polysorbates, while Span 80 (Sorbitan monooleate) is a sorbitan ester 
widely used in food products and oral pharmaceuticals. Tween 80 and Span 80 are generally 
regarded as non-toxic and non-irritating. According to the hydrophile-lipophile balance  system 
(HLB), surfactants with HLB values between 4 and 6 are suitable for making W/O emulsions. 
Therefore, a mixture of SPAN80 and Tween80 (9 parts of Span80 and 1 part of Tween80) with a 
resulting HLB value of 5 was used as emulsifier to prepare the W/O emulsions. 
In the preliminary stage of the work, the concentration of the organic, polymeric 
solutions, the volume of aqueous phase and emulsifier and the emulsification conditions were 
considered. The organic phase and the emulsifier were homogenized  in a glass vial with a 
magnetic stirrer, then the aqueous solution was added drop-by-drop under constant stirring. A 
magnetic stirring bar rotating at 1000 rpm was used for the emulsification process; a secondary 
stage of emulsification with ultrasonification was also considered. Preliminary electrospinning 
experiments were performed in order to evaluate the impact of the different parameters on 
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the electrospinning process. A optical microscopy was used to monitor the overall quality of the 
electrospun nets. Concentration and composition of the PLGA and PdlLA solutions resulted to 
be the particularly important for the formation of nanofibers during the electrospinning 
process. Stable emulsions were obtained by adding to the organic polymer solutions volumes of 
emulsifier ranging from 1/50 to 1/25 of the volume of the polymeric solutions. The volume of 
watery-phase with AlbF was successfully varied between 1/20 and 1/10 of the volume of the 
organic solutions. From the preliminary electrospinning experiments it was clear that larger 
amounts of water phase made the electrospinning process less effective and discontinuous. 
Generally, the presence of the emulsifier had a benign effect on the quality of the fibers and the 
overall process, but this effect was not related to the actual amount of emulsifier in the tested 
range. So, the volume of watery-phase and emulsifier were fixed at 1/20 and 1/50 of the oily-
phase volume, respectively. PLGA and PdlLA were dissolved in CL at a concentration of 17% and 
11%, respectively. Those values represented the best compromise between emulsion stability 
and quality of the electrospinning process for the present system of emulsifiers and solvents.     
As far as the emulsification process itself, confocal micrographs were used to determine 
dimension and distribution of the dispersed phase after each stage of emulsification. 
Figure 5-2a shows a confocal image of a W/O emulsion of a water solution of AlbF in a 
17% PLGA in CL; the emulsion was obtained by stirring the two solutions at 1000 rpm for 10 min 
on a conventional magnetic stirrer. 
Except in the short initial transient during the formation of the emulsion, the time of 
stirring was found not to be a significant factor in the emulsification process. As reported in the 
graph in Figure 5-2c, at front of a the time of stirring increased from 10 min to 1 hour, no 
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significative changes in the diameter and distribution of the water phase were found (from 5.6 
± 2.9 to 5.0 ± 2.9 µm). On the contrary, a similar emulsion was sonicated for 1 minute after 1 
hour of stirring (see Figure 5-2b), resulting in a significative decrease of the water drops 
dimension to 2.4 ± 1.4 µm. However, all the emulsions remained stable for several hours after 
the emulsification, and we chose to avoid the sonication to preserve both the loaded 
biomolecules and the molecular weight of the polymers. A similar behavior was found when 
11% PdlLA in CL was used as organic phase. 
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a. 
50 µm
 
b. 
    c. 
Figure 5-2. W/O emulsions consisting a 2 mg/ml water solution of ALbF dispersed in a 17% 
(wt) solution of PLGA in CL prepared with different emulsification methods. a.) W/O emulsion 
homogenized with a magnetic stirrer with magnetic bar rotating at 1000 rpm for 10 min; b.) 
W/O emulsion subjected to sonication for 1 min after stirring; c.) Diameter of the disperse 
phase as a result of different emulsification methods 
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Figure 5-3 demonstrates the distribution of loaded molecules in electrospun nanofibers 
prepared from W/O emulsions.  
50 µm50 µm
 
a. b. 
       c. 
Figure 5-3. Confocal images of a W/O emulsion of AlbF in and the corresponding electrospun 
nanofibers. a.) W/O emulsion consisting a 2mg/ml water solution of ALbF dispersed in a 17% 
(wt) solution of PLGA in CL (water phase/organic phase ratio equal to 1/20); b.) AlbF 
distribution in AlbF-loaded PLGA nanofibers obtained by electrospinning of the emulsion; c.) 
Schematic illustration of the microdroplets breakdown in the region of the Taylor cone and 
the formation of fluorescent nanoclusters along the nanofibers during electrospinning  
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A W/O emulsion consisting a water solution of ALbF dispersed in a 17% (wt) solution of 
PLGA in CL was electrospun on a glass slide. The resulting nanofibers were imaged with the 
confocal microscopy.  
AlbF was not homogeneously dispersed in the electrospun nanofibers; on the contrary, 
the entrapped biomolecules were confined in islands and rounded clusters along the 
nanofibers. It was not trivial to determine the dimension of those clusters, but we estimated 
that they ranged between 100 and 300 nm. It is interesting to recall that the dimension of the 
dispersed phase in the emulsion ranged between 1 and 8 µm. We think that large shear 
stresses and mechanical compression in the Taylor cone and in the linear region of the 
electrospinning induce an extended breakdown of the disperse phase, resulting in drastic 
reduction of the dimension of the drops. Evaporation of the solvent during the fiber formation 
may also contribute to the formation of the nanoclusters of the encapsulated molecules.  
5.3.2 Preparation of AlbF-loaded nanofibers by solution and emulsion 
electrospinning 
In Figure 5-4, AlbF-embedded nanofiber meshes prepared by solution electrospinning 
and emulsion electrospinning are compared. Nanofibers in Figure 5-4.a and Figure 5-4c were 
prepared by solution electrospinning of a one-phase, homogeneous pre-spinning solutions; 
nanofibers in Figure 5-4b and Figure 5-4d were prepared by emulsion electrospinning of a 
biphasic W/O emulsion.  
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Solution Electrospinning Emulsion Electrospinning 
100um
 
a. PLGAsol_AlbF 
100um
 
b. PLGAem_AlbF 
100um
 
c. PdlLAsol_AlbF 
100um
 
d. PdlLAem_AlbF 
Figure 5-4. Confocal images of PLGA and PdlLA nanofibers embedded with AlbF either 
prepared by one-phase, solution electrospinning (a.-c.) or by emulsion electrospinning (b.-d.). 
In the case of solution electrospinning the loaded AlbF was homogeneously dispersed 
into the nanofibers.  On the contrary - as previously  discussed - entrapped AlbF was confined in 
isolated nanoclusters along the fibers in the case of emulsion electrospinning. This is 
 141 
 
particularly evident in the PdlLA nanofibers prepared by emulsion electrospinning 
(PdlLAem_AlbF), where AlbF clusters are aligned with great regularity along the fibers (Figure 
5-4c). Emulsion electrospinning of PdlLA originated highly reproducible defect-free nanofibers 
and a high-quality electrospinning process. 
Instead, as it is possible to see in Figure 5-4b, PLGA nanofibers prepared by emulsion 
electrospinning (PLGAem_AlbF) presented several microscopic defects. It is worth to emphasize 
here that, regardless all our efforts, it was not possible to prepare PLGA W/O emulsions with 
optimal electrospinning properties. Discontinuity in the electrospinning jet, instability of the 
Taylor cone, high viscosity of the emulsion and fast solvent evaporation resulted in the 
formation of polymeric agglomerates at the tip of the needle. The process was also highly 
discontinuous; excellent fibers were obtained at times, but macroscopic and microscopic 
droplets, large fibers and aggregates were also deposited onto the collector (see also Figure 
5-5). At times, no electrospinning was obtained at all. We think that, due to its low molecular 
weight, PLGA in solution has a limited ability to withstand shear stresses during the formation 
of the fiber resulting in a instability of the polymer jet. In presence of a disperse phase, the 
polymer may not be able to overcome the increased viscosity of the emulsion. We also tried to 
use alternative solvents or mixtures of solvents (toluene and xylene between others) for the 
preparation of the PLGA organic solution. Regardless a large number of alternative 
formulations, no evident improvement of the process was found.  
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Figure 5-5. PLGAem_AlbF nanofibers with macroscopic solidified polymer drops, large fibers 
and aggregates (Scale bar 50µm) 
 
SEM micrographs in Figure 5-6 display the morphology of the different Alb-loaded 
electrospun nets. Cylindrical, smooth nanofibers were observed in all cases. Spindle-like defects 
and irregular diameters were found for PLGA nanofibers. It is interesting to compare confocal 
images and SEM micrographs for samples prepared by emulsion electrospinning (for instance 
compare Figure 5-4d and Figure 5-6d). Although encapsulated AlbF had a non-homogenous 
distribution and it was confined in clusters, nanofibers did not present any evident bulges or 
irregularities on the exterior.  
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Solution Electrospinning Emulsion Electrospinning 
 
a. PLGAsol_AlbF 
 
b. PLGAem_AlbF 
 
c. PdlLAsol_AlbF 
 
d. PdlLAem_AlbF 
Figure 5-6. SEM micrographs of PLGA and PdlLA nanofibers loaded with AlbF. a.) 
PLGAsol_AlbF nanofibers  were prepared by directly dissolving AlbF along with PLGA into a 
HFIP/water (7 to 1 vol.) solution; b.) PLGAem_AlbF nanofibers  were obtained from a W/O 
emulsion of a AlbF aqueous solution into 17% (wt) PLGA in chloroform; c.) PdlLAsol_AlbF 
nanofibers  were prepared by directly dissolving AlbF along with PdlLA into a HFIP/water (7 
to 1 vol.) solution; d.) PdlLAem_AlbF nanofibers  were obtained from a W/O emulsion of a 
AlbF aqueous solution into 11% (wt) PdlLA in chloroform 
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5.3.3 VEGF-loaded nanofibers prepared by solution and emulsion electrospinning 
In this study, electrospun nanofiber materials were prepared in which BSA was 
encapsulated along with VEGF. BSA is added as a protectant to the VEGF to prevent protein 
degradation and inactivation under extremely hostile environments, such a dissolution and 
dispersion in organic solvents during scaffold fabrication and protein encapsulation. In some 
manufacturing processes, the addition of albumin aided in protecting growth factors from 
denaturation in organic solvents [169],[170]. Other results suggested that BSA has the potential 
of stabilizing other protein or peptide drugs [171]. In addition, Valmikinathan et al. demonstrated 
that BSA helps in overcoming the most common drawbacks associated with hydrophobic 
polymers such as reduced loading efficiency, long degradation periods, and burst release [172].  
All nanofibers loaded with VEGF and BSA exhibited a defect-free morphology (Figure 
5-7) regardless the preparation method. Most likely, the presence of BSA increased the 
electrical conductivity of the solution, making the process of fiber drawing more efficient. 
However, very much like in the case of ALb, the electrospinning process of PLGA emulsions with 
VEGF and BSA presented several challenges. No large aggregates were observed, but the 
surface of the scaffold was interspersed with macroscopic and microscopic round defects 
originated by solvent-rich polymer droplets deposited over the time. Those defects are 
particularly harmful because of the residual solvent that could re-dissolve the nanofibers, and 
create discontinuities and even holes in the material.  
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Solution Electrospinning Emulsion Electrospinning 
 
a. PLGAsol_VEGF-BSA 
 
b. PLGAem_VEGF-BSA 
 
c. PdlLAsol_VEGF-BSA 
 
d. PdlLAem_VEGF-BSA 
Figure 5-7. SEM micrographs of PLGA and PdlLA nanofibers loaded with VEGF and BSA. a.) 
PLGAsol_VEGF-BSA nanofibers  were prepared by directly dissolving VEGF and BSA along with 
PLGA into a HFIP/water (7 to 1 vol.) solution; b.) PLGAem_VEGF-BSA nanofibers  were 
obtained from a W/O emulsion of an aqueous solution of  VEGF and BSA into 17% (wt) PLGA 
in chloroform; c.) PdlLAsol_VEGF-BSA nanofibers  were prepared by directly dissolving VEGF 
and BSA along with PdlLA into a HFIP/water (7 to 1 vol.) solution; d.) PdlLAem_VEGF-BSA 
nanofibers  were obtained from a W/O emulsion where an aqueous solution of  VEGF and BSA 
was dispersed into 11% (wt) PdlLA in chloroform 
 146 
 
 
5.3.4 In vitro VEGF release from PLGA and PdlLA nanofiber mats prepared by 
solution and emulsion electrospinning   
VEGF-loaded PLGA and PdlLA nanofiber materials prepared by solution and emulsion 
electrospinning were immersed in a phosphate buffer solution with 0.1% BSA to assess in vitro 
release of VEGF. Very dilute protein solutions more prone to inactivation and loss as a result of 
low-level binding to the storage vessel. Therefore, it is common practice to add proteins, such 
as bovine serum albumin (BSA) as carrier or filler to protect against such degradation and loss.  
Buffer solution with released VEGF was completely removed every 24 hours and replace 
with fresh medium. Samples extracted at day 1, 2 and 4 were analyzed using Quantikine® VEGF 
ELISA kit to determine the amount of release VEGF. Results are summarized in Figure 5-8. For 
all the experiments, we found release profile with a strong burst at day 1, an intermediate 
amount of release at day 2 and very limited release at day 4.  
The data suggest that, both in case PLGA and in case of PdlLA, samples prepared by 
emulsion electrospinning had a smaller amount of release at day 1 and a slightly more 
sustained release in the following days when compared with samples prepared by solution 
electrospinning. However, as no error bars are available, we cannot provide a conclusive result. 
In general term, the drug distribution along the fiber could explain a more gradual release in 
the case of samples prepared by emulsion electrospinning. As it results from confocal images, 
the clusters of encapsulated molecules in nanofibers prepared from emulsions appear to be 
located toward the center of the fibers (Figure 5-4b-d).  
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Figure 5-8. VEGF released in days 1, 2, and 4 from PLGA (a.) and PdlLA (b.) nanofibrous 
scaffolds. VEGF-loaded nanofibers were prepared either by directly dissolving VEGF or by 
emulsifying an aqueous solution of VEGF the polymeric solution. The content of active-VEGF in 
the release medium was determined by enzyme-linked immunosorbent assay (ELISA). The 
reported values represent the average of three separate release samples. (Release area 
3.14cm2) 
As a consequence, a limited amount of drug is available on the surface or near the 
surface of the nanofibers for immediate release. On the other side, encapsulated molecules 
have a more uniform distribution in nanofibers obtained from solutions (Figure 5-4a-c). Thus, a 
larger share of molecules on the surface could result in a larger immediate (burst) release.  
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PCL-PLGA_VEGF-BSA and PCL-PdlLA_VEGF-BSA composite scaffolds with a 
compositional and biochemical gradient along their thickness for spatially-confined release of 
VEGF to a specific surface of the scaffold were prepared according to the scheme in Figure 5-1. 
We used side-by-side release chambers presented in Chapter 3 to separate VEGF delivered to 
the opposite sides of the composite scaffolds. Release data for the PCL-PdlLA composite 
scaffolds are presented in Figure 5-9.  
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Figure 5-9. Average amount of VEGF released daily from the opposite surfaces of a PCL-PdlLA 
composite scaffold. VEGF and BSA were encapsulated in the PdlLA nanofibers by emulsion 
electrospinning and released in 0.1% BSA release medium. Active-VEGF content in the release 
medium was determined by ELISA. The reported values represent the average of three 
separate release tests. (Release area 3.14 cm2)   
The vast majority of the detected VEGF was release on side B, while very little amount 
of VEGF was found in the chamber on Side A. Again, as in the side-by-side experiments 
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presented in the previous chapters, composite scaffolds with internal gradients demonstrated 
the ability to confine with high efficiency the release of loaded molecules to a specific surface of 
the  scaffold. In this case, the efficiency of separation was higher than 93%. Unfortunately, no 
results were obtained with PCL-PLGA_VEGF-BSA composite scaffolds. Macroscopic defects and 
poor overall quality of PLGA nanofibers obtained from emulsion spoiled the side-by-side release 
test. 
 
In all the release experiments presented in this chapter, the amount of VEGF detected in 
the release media as soon as at day 4 was very limited. This result is in contrast with the 
findings that we presented in the previous chapters where an appreciable release of 
encapsulated molecules was demonstrated for 10 or more days. The reasons of this 
discrepancy are not clear. We think that the main reason is related to the detection technique 
itself. It is worth pointing out that ELISA kit can detect only active forms of the tested 
molecules. In fact, ELISA is designed to test protein activity based on the ligand (analyte)-
protein interactions. The protein activity in the body is based on a ligand-specific recognition. If 
the binding site is denatured, the interaction does not occur, and unbound proteins are washed 
away. In principle, detected VEGF contents presented in Figure 5-8 and Figure 5-9 are different 
from the total amount of released VEGF (active and inactive). In fact, the fraction of inactive 
molecules is not taken into account. If one could quantify the total amount of VEGF in the 
release media, regardless its ligand-specific activity, it would be possible to provide more 
complete results. Bicinchoninic acid (BCA) assay, micro BCA assay and Bradford Reagent have 
been tentatively used in the effort to determine the total content of VEGF. Unfortunately, a 
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quantification of the total amount of VEGF in the release medium was not trivial. In fact, the 
extremely low levels of VEGF (tens of nanograms per ml), the preponderant and virtually 
unknown release of BSA from nanofibers, along with the presence of BSA in the release 
medium, made conventional protein quantification techniques ineffectual.  
In relation to the release from PCL-PdlLA_VEGF-BSA composite scaffolds, we can 
estimate that the amount of VEGF detected in the release media accounted for about the 25% 
of the total VEGF encapsulated in the nanofibers. This means that about 75% of the loaded 
VEGF either was still in the fibers or was wasted cue to inactivation or denaturation. With data 
obtained here we cannot produce definitive results. For this reason, additional experimentation 
is necessary to determine the real efficiency of VEGF encapsulation, the complete release 
kinetics of VEGF and the VEGF/BSA ratio that maximize the release of functional proteins.  
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5.4 Conclusions 
In this chapter we will show a preliminary study for the encapsulation and the 
controlled-release of medically relevant biomolecules. We successfully encapsulated vascular 
endothelial growth factor (VEGF) in poly(lactide-co-glycolide) acid and poly(d,l-lactide) acid 
nanofibers by using both conventional solution electrospinning and emulsion electrospinning 
process. In the first case, VEGF was directly mixed into the polymeric solution; in the second 
case, a aqueous VEGF solution was emulsified within the organic polymeric solution. Release 
experiments demonstrated the delivery of functional biomolecules for at least 4 days, although 
the efficiency of the process and overall release kinetics are still partially unknown. In the 
present chapter, we also confirmed that composite scaffolds with a compositional and 
biochemical gradient have the ability to confine the release of VEGF to a specific region of the  
scaffold. In addition, by using fluorescently-labeled molecules, we showed that encapsulated 
molecules are evenly distributed in nanofibers prepared by one-phase solution electrospinning, 
while they are arranged in discrete periodic domains along nanofibers prepared by emulsion 
electrospinning. 
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6 FINAL REMARKS 
 
In this research work, a multicomponent scaffold for Vascular Tissue Engineering was 
designed, produced and characterized. The objective of this thesis was to prepare and 
characterize a tubular scaffold with adequate mechanical property, improved biocompatible 
surface for endothelial cell recognition and selective biomolecule release ability.  
In the first part of this thesis, we have demonstrated a double-electrospinning 
technique to produce a robust tubular scaffold with well-integrated nanofibrous structure, 
anisotropic mechanical behaviour and endothelial-conducive surface. The advantage of this 
approach resides in the combination of superior biological properties of a natural polymer (silk 
fibroin) with higher mechanical stability and performance of a synthetic degradable polyester 
(PCL). A thick bulk PCL mesh of nanofibers, an intermediate intermixed fibrous layer, and a thin 
layer of silk-fibroin nanofibers have been combined to form a multilayered structure which is 
stable against mechanical delamination. Using a rotating cylindrical collector, anisotropic 
mechanical behavior of these electrospun structures was obtained and the anisotropy is found 
to be dependent on the rotation speed of the collector. It was previously known that a rotating 
collector allowed to produce a tubular structure with anisotropic mechanical properties; 
however, we recognized for the first time that the combination of the collector shape and the 
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collector rotation allows to obtain tunable mechanical properties. In particular, previous studies 
failed to recognize partial alignment of nanofibers along the longitudinal direction with slender 
collectors rotating at low speed, which in turn results in higher mechanical properties in the 
longitudinal direction with respect to circumferential direction. In fact, at lower rotation speeds 
the structure was stiffer in the longitudinal direction and more compliant in the circumferential 
direction, reaching up to 2.5 in the longitudinal-to-circumferential ratio in this study. In this 
context, fibroin fibers acted as an “active” cell-conductive component that could actively 
dialogue with endothelial cells, and PCL fibers acted as a “passive” component that control 
mechanical and deformational behaviour of the scaffold.  
In the attempt to promote the “passive” PCL component of the scaffold to a more 
“active” role, we designed a graded electrospun structure able to sequester and deliver active 
biomolecules, while providing structural and mechanical integrity. In this view, we prepared a 
variety of tunable nanofiber micropatterns to control spatio-temporal release of one or 
multiple molecules. In fact, selective release of molecules that target specific cell types or tissue 
formation without influencing the activity of other cell populations or tissue functions is 
important to establish both in vitro physiological tissue models and in vivo tissue regeneration. 
Therefore, spatial and temporal control over release is critical to coordinate cell behaviors for 
healthy tissue formation. Herein, heterogeneous nanofibers scaffolds of PCL and PLGA with 
compositional and biochemical gradients along the scaffold thickness have been designed. 
Using PLGA nanofibers to encapsulate small molecules or proteins, we have characterized 
compositional and morphological changes as well as degradation behaviours of these 
composite scaffolds for up to 50 days in vitro. Using the precise graded composition and the 
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interplay between PCL and PLGA, we showed that the hierarchically-structured composite was 
capable of sustaining selective delivery of small molecules or larger proteins as well as multiple 
proteins to one specific side of the scaffold with efficiency of separation as high as 93%. We 
demonstrated that encapsulated molecules were released from one side of the scaffold with 
high efficiency of separation.  
Moreover, various release profiles of combined biomolecules could be achieved by 
modulating the nanofibers micropattern. Thus, we obtained simultaneous and sequential 
release of two different model proteins on the two surfaces of a newly engineered graded 
scaffolds, and we showed that timing and the kinetics of molecule release can be influenced by 
changing the initial pattern of drug distribution and the composition of the scaffold.  
We believed that scaffold preparation and release micropatterns presented in this work 
may represent the platform for the development of novel mechanically-competent scaffolds 
and multifunctional matrices able to actively control and direct the process of vascular tissue 
regeneration. However, the materials developed in this study can have also a broader impact in 
several fields of Tissue Engineering, where transitional components and active interfacial 
scaffolds with programmable and spatially controlled drug delivery ability are required. 
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